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ABSTRACT OF THE DISSERTATION 
BIOCOMPATIBILITY ASSESSMENT OF BIOSORBABLE POLYMER COATED 
NITINOL ALLOYS 
by 
Chandan Pulletikurthi 
Florida International University, 2014 
Miami, Florida 
Professor Norman Munroe, Major Professor 
Owing to an increased risk of aging population and a higher incidence of coronary 
artery disease (CAD), there is a need for more reliable and safer treatments. Numerous 
varieties of durable polymer-coated drug eluting stents (DES) are available in the market 
in order to mitigate in-stent restenosis. However, there are certain issues regarding their 
usage such as delayed arterial healing, thrombosis, inflammation, toxic corrosion by-
products, mechanical stability and degradation. As a result, significant amount of 
research has to be devoted to the improvement of biodegradable polymer-coated implant 
materials in an effort to enhance their bioactive response.  
In this investigation, magneto-electropolished (MEP) and a novel biodegradable 
polymer coated ternary Nitinol alloys, NiTiTa and NiTiCr were prepared to study their 
bio and hemocompatibility properties. The initial interaction of a biomaterial with its 
surroundings is dependent on its surface characteristics such as, composition, corrosion 
resistance, work of adhesion and morphology. In-vitro corrosion tests such as 
potentiodynamic polarization and electrochemical impedance spectroscopic (EIS) studies 
were conducted to determine the coating stability and longevity. In-vitro 
vii 
 
hemocompatibility studies and HUVEC cell growth was performed to determine their 
thrombogenic and biocompatibility properties. Critical delamination load of the polymer 
coated Nitinol alloys was determined using Nano-scratch analysis. Sulforhodamine B 
(SRB) assays were performed to elucidate the effect of metal ions leached from Nitinol 
alloys on the viability of HUVEC cells. Scanning Electron Microscopy (SEM), X-ray 
Photoelectron Spectroscopy (XPS), contact angle meter and X-ray diffraction (XRD) 
were used to characterize the surface of the alloys.  
 MEP treated and polymer coated (PC) Nitinol alloys displayed a corrosion 
resistant polymer coating as compared to uncoated alloys. MEP and PC has resulted in 
reduced Ni and Cr ion leaching from NiTi5Cr and subsequently low cytotoxicity. 
Thrombogenicity tests revealed significantly less platelet adhesion and confluent 
endothelial cell growth on polymer coated and uncoated ternary MEP Nitinol alloys. 
Finally, this research addresses the bio and hemocompatibility of MEP + PC ternary 
Nitinol alloys that could be used to manufacture blood contacting devices such as stents 
and vascular implants which can lead to lower U.S. healthcare spending. 
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CHAPTER 1 
INTRODUCTION 
1.1 Biomaterials 
 A biomaterial is defined as “any material used to make devices to replace 
a part or a function of the body in a safe, reliable, economic, and physiologically 
acceptable manner”[1]. It is also defined as “a material intended to interface with 
biological systems to evaluate, treat, augment or replace any tissue, organ or function of 
the body” by D. F. Williams et al. [2].  
1.1.1 History of biomaterials  
 The history of biomaterials can be traced back to various civilizations, such as in 
early 600 A.D., the Mayans used sea shells for nacre teeth, and in around 130- 200 A.D., 
Greeks used gold sutures for wound healing [3]. The introduction of aseptic surgical 
procedures by Dr. Joseph Listerin in the 1860s dramatically reduced the post-operative 
infections and failure of biomaterials[4]. In 1891, Glück [5] developed an ivory ball and 
socket joint that was attached to the bone with nickel-plated screws. By the early 1900s, 
ivory and boiled cadaver bones were successfully used as bone graft materials [6]. In 
1930, Alexis Carrel, a French surgeon and noble laureate, in collaboration with aviator 
Charles Lindbergh, invented a mechanical heart that circulated vital fluids through 
excised organs [7]. By the 1950s-1960s, blood vessel replacements were in clinical trials 
[6],[8]. From 1960 onward, development of synthetic biomaterials, such as silicones, 
polyurethanes, teflon, hydrogels, poly ethylene glycol (PEG), hydroxy apatite, bioglass 
and titanium led to large-scale production of several medical products for enhancement of 
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the quality of human life [9]. Aforementioned biomaterials are used in various medical 
devices, such as intravascular access devices, replacement for infected or injured body 
parts, devices for repairing broken bones, internal and external pacemakers, implantable 
pulse generators (IPGs), implantable cardiac defibrillators (ICDs), ophthalmic implants 
and components for cosmetic surgeries, etc.[10]. In 1982, Dr. Robert Jarvik successfully 
implanted the first permanent artificial heart [7]. However, there has been a prevailing 
and steady increase in health problems associated with cardiovascular diseases (CVD), 
such as coronary heart disease, stroke, and heart failure (mortality rate 40.6%) [11] in 
patients due to their lifestyle (obesity, physical inactivity, improper food habits, etc.) [10, 
11]. Subsequently, there is a great need for cardiovascular implants that are more 
efficient, durable and could effectively overcome the drawbacks of currently used 
implants in coronary angioplasty.  
1.2 Classification of biomaterials 
 Biomaterials can be classified into two groups based on their origin, namely 1) 
natural and 2) synthetic biomaterials. Collagen, gelatin, cellulose, starch, polysaccharides 
and fibrin are some of the natural biomaterials used in tissue engineering, drug delivery, 
wound closures, capsule coatings, dental and orthopedic applications, etc.[3]. Polymers, 
metals, ceramics and composites were considered as man-made or artificial biomaterials 
that were used for cardiovascular, ophthalmic, orthopedic, urological, carnio-facial and 
dental applications. Also, biomaterials can be categorized based on their physical and 
chemical properties. 
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Table 1.1 shows the classification of biomaterials based on the type of material 
used. 
Table 1.1: Biomaterials used in human body [10, 12, 13] 
Type of material Examples Applications 
Polymers Nylon, silicones, teflon, 
polyester fibers, high strength 
acrylics, polyurethane, hydro 
gels, polycarbonate, 
polypropylene, dacron, poly 
(methyl methacrylate) 
Contact lenses, vascular grafts, 
wound dressings, maxillo 
facial operations, absorbable 
sutures, drug- release systems, 
renal dialysis cartridges, 
trocars, extra cellular matrices
Metals Titanium, titanium alloys, 
cobalt-chromium alloys, 316 L 
stainless steels, platinum 
alloys, silver, magnesium 
alloys 
Joint replacements, dental 
root implants, bone screws, 
bone plates, bone grafts, 
cardiac stents, electrodes, 
anti-bacterial material 
Ceramics Alumina,  zirconia, 
hydroxyapatite, bio-glass 
Joint replacements, bone 
spacers, tooth implants, bone 
bonding applications, bone 
cement fillers 
Composites Carbon – carbon, calcium 
Phosphate cement 
Joint implants, heart valves 
  
 Based on the potential risk for illness or injuries presented by a malfunction or 
failure of an implant, the Food and Drug Administration (FDA) has classified them into 
three categories [14-16] [17, 18]. Class I devices do not come in direct contact with body 
fluids, present the lowest safety risk and are subjected to general controls. Class II 
devices intermittently come in contact with tissues. They have to go through general and 
special controls involving labeling requirements, mandatory performance standards 
(require a 510(k), or premarket notification) and adequate surveillance. Class III devices 
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(implants) always stay in contact with tissues and body fluids. Additionally, they fulfill 
the screening standards for Class I and II, and undergo scientific reviews and clinical 
trials. Depending on the interaction of the biomedical implant with the human body 
(physiological environment), Class III devices are again classified into three groups [15, 
19], as shown in Figure 1.1. Bio-inert materials (alumina, titanium and partially stabilized 
zirconia) are those that have minimal tissue interactions, which do not lead to 
immunological host reactions and retain their structure after implantation. Bio-active 
materials (synthetic hydroxyapatite (Ca10(PO4)2(OH)2), Nitinol, bio-glass) in general 
mimic and interact with their surrounding physiological environment and generate 
required host response. Bio-degradable materials (magnesium alloys, tri-calcium 
phosphate implant (Ca3(PO4)2), biodegradable polymers, etc.), after serving the purpose 
of their implantation, will eventually degrade into biosorbable degradation products and 
will be slowly replaced by the regenerating tissues[19] [20, 21].  
 
Figure 1.1: Classification of biomaterials according to FDA [15]. 
As shown in Figure 1.2, the medical device industry is currently using the 
aforementioned biomaterials to manufacture different implants for numerous medical 
applications.  
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Figure 1.2: Different implants and devices used to replace or enhance the functions of 
diseased or missing tissues and organs [10] 
1.3 Biocompatibility 
From the 1940s to the 1980s, the concept of biocompatibility for the first-
generation implantable medical devices was assumed as the long lasting durability of 
implant materials in the human body [22]. However, in 1987, this concept was redefined 
as “the ability of a material to perform with an appropriate host response in a specific 
situation [23]. 
This can be understood more clearly by looking at three categories. The first one 
considers the ability of the material to interact and perform with the host body rather than 
to remain inert. The second focuses on the implant’s responsibility to generate an 
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appropriate response from the host for the required application. The third category 
addresses the nature of the response to a material, which may vary from one situation to 
another [24]. The two main factors which influence the first category of biocompatibility 
are: 1) the degradation of the material once implanted; and 2) the reaction of the host in 
response to the implanted material. These two factors were the focus of this investigation.   
1.4 Nitinol 
Nitinol was first invented in 1958 by a metallurgist named William J Buehler. The 
term “Nitinol” was derived by taking the first two letters of the constituent elements 
nickel and titanium, followed by the first letters of the name of the laboratory in which it 
was discovered – the Naval Ordinance Laboratory. The shape memory effect of Nitinol 
was serendipitously found in 1961, when the alloy came in contact with a lit cigarette. 
This invention has resulted in a vast number of industrial applications. Generally, Nitinol 
exhibits shape memory effect as well as super elastic properties at a composition 
corresponding to approximately 55 wt% Ni and 45 wt% Ti (49.5 to 53 at% Ni). The 
phenomenon of shape memory effect and super elasticity of Nitinol were explained 
through crystallography by Dr. Frederick E. Wang [25]. 
1.4.1 Shape memory effect 
Shape memory effect can be described as a thermal effect in which solid to solid 
phase transformation occurs due to a temperature change, or in other words, the material 
regains its predetermined shape once it is heated above its transformation temperature 
(thermal shape memory effect). In the case of Nitinol, it consists of two phases: 
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Austenite, which is a stable parent phase that exists above the transformation temperature 
range (TTR) and Martensite, a less stable phase, which exists below the TTR [25]. When 
Nitinol in its austenitic phase is cooled, it transforms to martensite, which when deformed 
and heated above its TTR, regains its original shape. The shape memory effect of Nitinol 
is schematically illustrated in Figure 1.2, where austenite is cooled to twinned martensite, 
which can be deformed. After heating, Nitinol is converted into austenite and returns to 
its original shape. As was previously mentioned, this transformation temperature range 
depends mainly on the atomic composition of Ni and Ti in Nitinol. Subsequently, the 
TTR can vary from 100 ºC to very low temperatures [26]. The application of Nitinol in 
diverse fields, such as the manufacturing of medical devices, electrical components and 
military applications, was feasible due to the production of Nitinol with varied TTRs. 
1.4.2 Pseudo elasticity 
Austenitic Nitinol behaves like a plastic material. When a force is applied just 
above the TTR, the material yields to the applied stress by changing its crystal structure 
to a martensitic phase (stress-induced martensitic transformation) [27]. However, 
removal of stress converts the martensitic phase back to austenite, thus regaining its 
original shape (non-linear super elasticity) [28]. This occurs due to the reversible motion 
of domain boundaries during the phase transformation, rather than just bond stretching or 
the introduction of defects in the crystal lattice [29]. In this temperature range, even with 
multiple loading and unloading cycles, Nitinol does not exhibit any plastic deformation 
due to its elastic properties [30]. Unlike the shape memory effect, here the transformation 
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from austenite to martensite occurs because of the application and removal of stress, once 
above the austenitic formation temperature (Af).  
 
 
 
Figure 1.3: Stress–strain-temperature diagram of Nitinol 
 Figure 1.3 illustrates a combined diagram of thermal shape memory effect and 
super elastic properties of Nitinol, where As – Start of austenitic transformation 
temperature, Af – finish of austenitic transformation temperature, Ms – Start of 
martensitic transformation temperature, Mf – finish of martensitic transformation 
temperature. The stress-strain curve (loading and unloading curve), which starts from 
“O” austenitic phase and reaches “A” martensitic phase by application of stress and 
returns to its original austenitic phase (point O) by removal of stress, depicts the pseudo-
elastic behavior of Nitinol. The thermal shape memory effect of Nitinol is explained by 
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three different sections: the curve “OA” shows the transformation of austenitic phase to 
twinned martensitic phase by lowering the temperature below TTR; the curve “AB” show 
the transformation of twinned martensite to martensite by application of stress; the curve 
“BC” shows the plastic deformation that has occurred by the application of stress; the 
curve from “C” to “O” depicts the conversion of deformed martensitic phase to original 
austenitic phase, by the application of temperature.  
1.4.3 Biocompatibility of Nitinol 
 Metallic biomaterials are known for their widespread usage in the fields of dental, 
cardiovascular, maxillofacial and orthopedic implants [31]. Bio and hemocompatibility of 
an implant, which are dependent on its corrosion resistance, surface and mechanical 
properties, will in turn decide its longevity. Initially, usage of copper, silver, nickel, 
aluminum and magnesium alloys for long-term implantation was restricted due to their 
high reactivity and toxic nature [32]. Later on, steel, chromium, and titanium alloys 
which were known to spontaneously form a stable passive oxide layer on their surface, 
with improved biocompatibility, were used to manufacture the long-term metallic 
implants [33]. However, after implantation, these alloys were subjected to highly 
corrosive and a complex physiological environment, which consists of water, dissolved 
oxygen, proteins, minerals, chloride and hydrogen ions, etc., that can eventually lead to 
corrosion degradation. This results in limited longevity of the implants [34, 35] and 
repetitive implant replacement surgeries.  
Nitinol (an equiatomic alloy of nickel and titanium) that belongs to the class of 
titanium alloys has been successfully employed in manufacturing several medical 
10 
 
devices, such as peripheral vascular products (self-expanding stents, graft support 
systems, guide wires) [36], endovascular aneurysm repair devices (filters and baskets), 
inferior vena cava filters and embolic protection devices. Its wide applications in the field 
of medical implants were due to its super elastic, shape memory and excellent 
biocompatibility properties. Nitinol, under normal atmospheric conditions, forms a 
protective passive surface oxide layer that mainly consists of TiO2 oxide (free energy of 
formation, ∆G at 298 K of TiO2, NiO and TiO are -212.6, -50.6 and 118.3 Kcal mol-1) 
[37]. This is known to render good corrosion resistance to this alloy. However, due to the 
harsh physiological environment present inside the human body, Nitinol implants are 
known to undergo pitting and crevice corrosion [38]. The other factors that influence the 
corrosion properties of Nitinol are discussed in detail in Chapter 3. Additionally, after 
implantation there are concerns regarding the toxic and allergenic effects of Ni released 
by corrosion of Nitinol (which consists of high amount of Ni ~50 at% in its 
microstructure) [39-42]. Alloying, surface preparation [29] and manufacturing methods 
are some of the ways through which the corrosion properties of Nitinol can be modified. 
1.4.4 Applications of Nitinol 
Nitinol in various shapes (wires, rods, porous scaffold, plates, screws and meshes) 
and sizes is used for a range of implantable medical devices. Excellent biocompatibility, 
unique shape memory affect and super elasticity properties exhibited by Nitinol, resulted 
in a boom of its applications in medical industries. Listings of typical applications are as 
follows [26, 43-50]: 
 Cardiovascular stents 
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 Orthodontic tooth alignment wires 
 Inferior vena cava filter  
 guide wires for catheters 
 Needle wire localizers 
 Intervertebral body fusion device (artificial disc) 
 Vertebral Body staples 
 Lumbar inter body fusion devices 
 Anterior cervical inter body fusion devices 
 Intramedullary nails 
 Porous dental implants 
 Surface coating for hip and knee prostheses 
 Maxillo-facial and cranial repairs 
 Bone graft substitutes 
 Hybrid vascular grafts 
 Soft tissue repair and replacement 
 Effective material in plastic surgery and osseous oncology 
 Manufacture of cryosurgery tools 
 Manufacture of minimally invasive implant surgical devices 
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CHAPTER 2 
STENTS 
2.1 Cardiovascular diseases (CVD) 
 According to American Heart Association (AHA) statistics, each day more than 
2,150 Americans die due to CVD, which is an average of 1 death every 40 seconds [51]. 
Additionally, in America, 34% of deaths before the average life expectancy of 78.5 years 
were related to CVD. In 2009, one out of every six deaths in the United States was 
caused by coronary heart diseases [51]. Each year, an estimate of ≈635,000 Americans 
have a new coronary attack (defined as first hospitalized myocardial infarction or 
coronary heart disease death) and ≈280,000 have a recurrent attack. It is estimated that an 
additional 150,000 silent first myocardial infarctions occur each year. [51]. In 2009, the 
Center for Disease Control and Prevention (CDCP) estimated that around 785,000 
Americans had experienced a coronary attack, and about 470,000 will have a recurrent 
attack [52]. 
 
Figure 2.1: Prevalence of CVD in adults ≥ 20 years of age [53]  
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Figure 2.2: Deaths due to heart diseases in the United States [53]  
 According to the National Health Interview Survey (NHIS), in 2011, about 15.3 
million cases of coronary diseases were observed [54] due to atherosclerosis (buildup of 
fat, cholesterol, etc., that lead to formation of plaque and hardening of the arteries). It is 
projected that by 2015, there will be 133 million Americans over 45, the age at which the 
incidence of heart disease is documented and at least 40% of those will have some form 
of CVD by 2030 [55]. Also, due to the present lifestyle, there is an increased risk of 
coronary artery disease that will result in a growth rate of percutaneous coronary 
intervention (PCI) procedures of roughly 3%–5% overall [56]. Thus, the largest growth 
factor for the medical device market in developed countries is found in the aged 
population.  
2.2 Bare metallic stents 
 Bare metallic stents (BMS) were first launched into the medical field in order to 
avoid restenosis, which leads to blockage of arteries after angioplasty [57]. BMS act as a 
mechanical scaffold for blood vessels and helps to prevent the artery from re-narrowing 
and the need for a repeat procedure. The medical term for this narrowing is stenosis and 
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when it reappears, it is called "re-stenosis" or simply, restenosis. However, about 25% of 
the time, the arteries may become blocked again after placement of a BMS.  
 Metallic stents have been manufactured from a variety of alloys, such as stainless 
steel, Nitinol, CP Ti, Ti-6Al-4V alloy and cobalt-nickel that are compatible with the 
human body [58]. Micro patterned surfaces have been introduced in an effort to influence 
cell adhesion and proliferation [59]. However, even with this improvement, in some 
patients based on their health conditions, the problem of in-stent restenosis reappeared. 
Many techniques, such as heat treatments (annealing, cold drawing and oxidation), 
surface treatments (passivation, electropolishing and anodization) [60] and application of 
protective coatings were adopted to improve the bio-compatibility properties of BMS 
[61]. Table 2.1 lists various metals [58],[62] that have been used for manufacturing 
stents. 
Table 2.1: Various metals that can be used to manufacture implants [63-67] 
Type of material 
Modulus of 
elasticity (GPa) 
Tensile 
strength (MPa) 
Corrosion resistance 
(mm/Year) 
Stainless steel - 316 L 
(annealed ASTM 138) 
200 490 29 x 10-3 
Co–Cr alloy  210 860-790 - 
Ti-6Al-4V alloy (Gr. 23) 105 950 35 x 10-3 
WE43 magnesium alloy  44 220 9.0 
Nitinol 75-83 195-690 0.10-2.26  
Nitinol alloys 96-99 630-680 0.02-0.11  
Arterial wall  0.001 0.50-1.72 - 
Cortical bone  5-23 35-283 - 
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2.3 Evolution of drug eluting stents 
 The main reason behind the usage of drug eluting stents (DES) as compared to 
BMS is to avoid renarrowing of coronary arteries that is caused by “in-stent restenosis”. 
In-stent restenosis occurs usually 3 to 6 months [68] after the implantation of BMS, 
which results in the growth of a scar tissue at the place of contact between the stent 
material and inner surface of the blood vessel, which eventually leads to re-blockage of 
the artery [68]. In an effort to mitigate in-stent restenosis, BMS were covered with a thin 
polymer coating programmed to release anti-proliferative drugs over an extended period. 
This technique obviated the development of scar tissues or in-stent restenosis and led to 
the evolution of DES [69]. Depending on the nature of the drug and the carrier polymer 
used, such as the drug’s water solubility and oil/water partition coefficient [70], the drug 
elution rate will change. In smaller coronary arteries (diameter < 3.0mm), DES are more 
effective than BMS in overcoming restenosis and neointimal hyperplasia (natural vessel 
response to injury healing) as compared with larger coronary arteries (diameter > 3.0mm) 
[71],[72],[73]. In the treatment of multi-vessel coronary disease, the mean total number 
of stents implanted in a patient is 2.68±0.95 (2.25±1.25 DES and 0.43±0.72 BMS) [56]. 
The mean total length of the stents was 62.78±29.13 mm, and the mean stent diameter 
was 3.05±0.46 mm [56]. Over six million DES have been implanted and it is only after 
very widespread use that the rare complications emerge (worldwide complications 0-3%); 
most researchers are currently saying that the chance of late stent thrombosis is around 
0.6% - less than 1 in 100. However, there has been a decline in DES sales due in part to 
thrombosis (development of a blood clot) [74, 75]. Thrombosis occurs in about two out of 
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1000 stable patients per year equipped with DES. Clinical trials conducted with more 
than 8,000 patients over three years revealed that thrombosis occurred in 2.9% of 
patients, but only in 1.2% after 30 days (similar to BMS) [76]. In order to avoid long-
term thrombosis after DES implantation, patients are advised to use anticoagulants, such 
as aspirin (75mg/day) and clopidogrel (100mg/day), for 6-12 months following the 
percutaneous coronary intervention (PCI) [77]. DES available in the U.S market are 
mainly composed of durable polymer coatings for drug delivery. The presence of the 
non-degradable polymer coating on DES after drug delivery is known to create 
complications, such as delayed arterial healing due to lack of endothelial coverage [78], 
thrombus formation [79], chronic arterial wall inflammation [80], aneurism formation 
[81], polymer disruption during stent delivery (bridging, peeling, blistering, cracking, 
etc.), late stent thrombosis (LST) and late-acquired stent mal-apposition [82-88]. Usage 
of anti-proliferative drugs, such as sirolimus, zotarolimus and paclitaxel, in DES not only 
reduces in-stent restenosis but also inhibits proper endothelialization near the stented 
arterial wall [89]. Delayed arterial healing due to the persistent fibrin deposition and poor 
re-endothelialization on DES, even after 30 days of implantation, might act as trigger 
sites for LST formation [84]. Discontinuation of antiplatelet therapy after DES 
implantation might lead to late restenosis and late stent thrombosis. Finally, DES are 
much more expensive than BMS [77]. 
 As such, a new generation of DES equipped with biodegradable polymer coating 
has been developed and is currently under clinical studies [90]. Biodegradable polymer 
coatings on DES provide an initial platform to carry and regulate the release of the 
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embedded drug and then eventually degrade into harmless bi-products that can be 
processed by the human body. Also, they are expected to overcome some of the 
aforementioned drawbacks that were observed in DES equipped with durable polymer 
coatings. In-vivo studies conducted by Joner M. et al. [91], demonstrated an improved re-
endothelialization in rabbits iliofemoral artery by the usage of DES. However, an excess 
of late loss (reduction in vessel diameter after stent implantation) [90], lack of reduction 
in stent thrombosis [92, 93], and a high inflammatory reaction due to major particle 
debris (coating degradation),were some of the limitations of DES with biodegradable 
polymers. Consequently, the complex process of designing and developing a DES with 
biodegradable polymer coating remains a challenge. 
 As a result, the Food and Drug Administration (FDA), the AHA and others are 
calling for a new generation of stents and new designs that are more adaptable to the 
arteries. The future of biomaterials, therefore, depends on a better understanding of 
mechanisms, by which they can be rendered stable and inert but yet retain flexibility, 
machinability, good biocompatibility and hemocompatibility. 
2.4 Hypothesis 
 The hypothesis of this research is that the application of a novel biosorbable 
polymer coating on MEP ternary Nitinol alloys will improve their biocompatibility with 
reduced thrombogenicity. 
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2.5 Research objective  
 The objective of this research is to focus on the biocompatibility, 
hemocompatibility and corrosion resistance of polymer coated ternary MEP Nitinol 
alloys. 
 The surface characteristics of ternary Nitinol alloys were expected to improve by 
employing magnetoelectropolishing (MEP) treatment and biodegradable polymer 
coatings to enhance their bio and hemo-compatibility properties. These treatments affect 
the below-mentioned properties: 
1. Corrosion resistance 
2. Surface chemistry, speciation and depth profile 
3. Hemocompatibility 
4. Polymer coating stability 
5. Wettability, surface free energy and work of adhesion 
6. Toxicity of leached ions 
 Different analytical techniques, such as In Vitro corrosion tests, ICPMS analysis, 
SEM, SEM/EDS, XPS analysis, FTIR, nano-scratch tests and contact angle, were 
employed to evaluate the aforementioned phenomenon. 
 The cytotoxic effect of the Ni ions released during the corrosion of polymer 
coated alloys on HUVEC cells was studied by performing Sulforhodamine B (SRB) 
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assays. Additionally, hemocompatibility of the samples was studied by platelet adhesion 
tests, which was conducted in a laminar flow chamber. 
The purpose of this research is to:  
1. Develop a biodegradable polymer coated ternary Nitinol alloy. 
2. Determine in-vitro corrosion rates and polymer coating stability via 
potentiodynamic polarization and electrochemical impedance spectroscopy (EIS), 
respectively. 
3. Characterize the polymer coated alloys and determine the polymer/substrate 
adhesion. 
4. Assess biocompatibility and hemo-compatibility via endothelialization and in-
vitro platelet adhesion studies on polymer coated and uncoated Nitinol surfaces. 
A schematic of the proposed research plan is shown in Figure 2.3. 
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Figure 2.3: Schematic of the proposed research plan. 
2.6 Potential polymers that can be used as coatings for stents 
 Various biodegradable polymers that are used in medical device industry and their 
properties are shown in Table 2.2.  
Table 2.2:  Hydrolytically degradable polymers [94],[95]. 
Name Monomer structure Properties Applications 
Degradati
on 
Poly(α
esters)  
 
Polyglycol
ide (PGA) 
 
Tg = 35 to 
40oC, Tm > 
3000o C, 45 
to 55% 
crystallinity, 
biodegradab
le synthetic 
Resorbable 
sutures (Dexon®), 
bone internal 
fixation devices 
(Biofix®) 
Strength is 
lost in 1 to 
2 months 
by 
hydrolysis 
and  mass 
is lost 
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polymer, 
elastic 
modulus ~ 
12.5GPa 
within 6 
to12 
months 
Polylactid
es (PLA) 
 
Tg = 60 to 
65o C, Tm > 
175o C, ~ 
37% 
crystallinity, 
elastic 
modulus  ~ 
4.8 GPa, 
semi-
crystalline 
polymers 
Orthopaedic 
fixation devices 
(BioScrew®, Bio-
Anchor®, 
Meniscal 
Stinger®- 
Linvatec), and 
ligament 
replacement 
devices 
Strength is 
lost in ~ 6 
months  by 
hydrolysis 
and toal 
mass 
resorption 
in 2 to 5.6 
years 
Polydioxa
none 
(PDS) 
 
Tg = -10 to 
0o C, Tm = 
110-115⁰ C, 
elastic 
modulus ~ 
1.5 GPa, 
crystallinity 
37% and 
hydrophobic
ity 
monofilament 
suture (Dixon®), 
suture clip, bone 
pin 
(OrthoSorb®),Fix
ation screws 
Strength is 
lost in 1 to 
2 months 
by 
hydrolysis 
and Mass is 
lost  within 
6 to 12 
months 
Polycaprol
actone 
(PCL) 
 
Tg = -60o C, 
Tm = 55 to 
60o C, non-
toxic, low 
tensile 
strength ~ 
23MPa, high
elongation 
at breakage 
> 700%, 
high 
permeability 
to many 
drugs 
Long-term 
contraceptive 
device 
(Capronor®), 
monofilament 
suture 
(Monacryl®), 
biologically 
active molecules 
(SynBiosys®) 
Slow 
hydrolytic 
degradation
, Mass 
resorption 
in 2 to 3 
years  
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Poly(trime
thylene 
carbonate) 
 
excellent 
flexibility, 
poor 
mechanical 
strength 
Flexible suture 
materials 
(Maxon®), 
orthopaedic tacks 
and screws 
(Acufex®), 
Suture(BioSyn®) 
Mass 
resorption 
in 3 to 4 
months 
Bacterial 
polyesters: 
poly(3-
hydroxybu
tyrate) 
High 
crystallinity, 
  
Polyur
ethane 
Polyuretha
ne 
 
Excellent 
biocompatib
ility, 
mechanical 
properties,  
favourable 
cell 
adhesion 
and 
proliferation 
Cardiac 
pacemakers, 
vascular 
grafts,porous 
scaffold 
(Degrapol®),  
injectable 
hydrogels 
systems 
(PolyNova®), 
bone cements 
 
Degradatio
n occurs by 
hydrolysis 
of urethane 
and 
aliphatic 
bonds 
Poly(e
ster 
amide) 
[96] 
Polydepsi
peptide 
 
good 
mechanical 
and thermal 
properties 
Site specific drug 
and peptide 
delivery system 
(Cameo®) 
 
Poly(o
rtho 
esters) 
Poly(ortho 
ester) IV pH sensitive 
(Alzamer®) as a 
hydrophobic, 
surface eroding 
polymer for drug 
delivery 
applications 
Usually 
very slow 
degradation 
rate but can 
be 
controlled  
using diols 
with 
varying 
levels of 
chain 
flexibility 
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Poly 
anhydr
ides 
Poly 
anhydride 
  
(Gliadel® Wafer) 
localized drug 
delivery to 
diagnosed high-
grade malignant 
glioma 
Hydrolytic 
bulk 
degradation 
occurs over 
days to 
months by 
varying the 
type and 
ratio of the 
monomers 
 
2.7 Market  
 Due to a 3-5% increase in percutaneous coronary intervention (PCI), the 
worldwide market for coronary stents increased to $7 billion by 2008 [97]. This stent 
market is mainly composed of BMS, DES, and novel bio-absorbable stents, which are 
currently under clinical trials. The DES market in the US is expected to increase by 9.0% 
from 2011 to 2016, due to the aging population, increase in obesity rate and a demand for 
minimally invasive procedures [98]. Usage of DES replacing BMS has led to a 
significant reduction in in-stent restenosis, repeat revascularization and mortality rate of 
dialysis patients with cardiac problems [99],[100]. However, DES is fraught with certain 
patho-physiological factors, such as stent-thrombosis, which can ultimately lead to 
myocardial infarction and mortality [101, 102]. 
2.8 Commercial products 
 As previously mentioned, the worldwide market for coronary stents is estimated 
to be greater than $7 billion, with annual growth estimated at more than 5%. The 
different kinds of DES that were approved by the FDA through a major clinical trial and 
introduced into the United States market are given in Table 2.3. 
24 
 
Table 2.3:  Commercially available DES and their properties [91] 
Name Drug (µg/mm2 ) Carrier polymer 
Polymer 
thicknes
s (mm) 
Strut 
thickne
ss (mm) 
Stent 
platform 
Cypher Sirolimus (1.4) 
polyethylene-co-
vinyl acetate 
(PEVA) and 
poly n-butyl 
methacrylate 
(PBMA). 
Durable 12.6 140 Stainless steel 316L 
Taxus 
Liberté 
Paclitaxel 
(1.0) 
SIBS 
[poly(styrene-
bisobutylene- 
b-styrene)], 
Bio-
degradable 16 97 
Stainless 
steel 316L 
Endeavor Zotarolimus (10) 
Phosphorylcholi
ne (PC)  5.3 91 
Cobalt 
alloy 
XIENCE 
V 
Everolimus 
(1.0) Fluoropolymer Durable 7.6 81 
Cobalt-
chromium 
alloy 
EXCEL Sirolimus 
Poly 
lactic acid 
(PLA) 
Bio-
degradable - - 
Stainless 
steel 
LUC-
Chopin2T
M, 
Balton 
(Poland) 
Paclitaxel 
(1.0) 
copolymer of 
lactic and 
glycolic acid 
Bio-
degradable - 0.12 
Stainless 
steel 316L 
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CHAPTER 3 
CORROSION OF IMPLANT MATERIALS 
3.1 Corrosion mechanism 
Corrosion is defined as “the destructive attack of a metal by chemical or 
electrochemical reaction with its environment [103]. Corrosion of a metallic implant is 
mainly controlled by two features, namely corrosion thermodynamics and corrosion 
kinetics [104-106]. Corrosion of a metal occurs due to its basic thermodynamic tendency 
to restore to a more stable compound, thereby bringing its free energy to a lower state, 
such as oxides and hydroxides, and etc. [103]. Corrosion thermodynamics is dependent 
on the energy released or absorbed during the redox (oxidation and reduction) reaction 
that occurs at the interface of the implant and its surrounding environment. From an 
electrochemical point of view, when a metal (M) is immersed in a solvent, the metallic 
ions (M+) from the metal’s surface start moving into the solution (anodic reaction) and 
this leads to accumulation of electrons (e-) on the surface of the metal. Eventual build of 
negative charge on the metal’s surface will start attracting M+ ions back on to its surface 
(cathodic reaction). Depending on the composition, pH, and temperature of the 
electrolyte, both the anodic and cathodic reactions reach an equilibrium point. This 
potential observed on the surface of the metal when no external potential was applied to 
the metal is called its equilibrium potential or rest potential (E0). The basic oxidation 
reaction (anodic reaction) that occurs during the corrosion process involves conversion of 
metal to metallic ions (increase of valence or loss of electrons).  
M ↔ Mn+ + ne-   (3.1) 
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 The thermodynamic driving force for the oxidation of metal to metallic ions is 
called free energy (∆G) and the corresponding equation is  
∆Gred = ∆Go + RT ln [M] / [Mn+] [e]n   (3.2) 
where ∆Gred is the free energy of reduction. 
The corrosion process will take place only when a counter reduction reaction (cathodic 
reaction) occurs in the electrochemical system depending on its surrounding conditions, 
such as ionic concentration, dissolved oxygen and pH. Various reduction reactions that 
might occur during a corrosion process are [106]: 
       2H+ + 2e- → H2                               at      pH < 7                                  (3.3) 
										2H2O	+2e‐	→	H2	+	2OH‐	             at       pH ≥7                              (3.4) 
                        4H+ + 4e- +O2 →	2H2O															at								pH < 7                              (3.5)	
																											2H2O	+	4e‐	+	O2	→	4OH‐	 			at							pH ≥ 7                                     (3.6)	
																											Mn+	→	M(n‐1)++	e‐																																																																																																														 (3.7)	
 Equations 3.3 and 3.4 are considered as hydrogen evolution reactions that occur in 
the absence of dissolved oxygen. However, Equations 3.5 and 3.6 are considered as 
oxygen reduction reactions and they occur in the presence of dissolved oxygen [107]. 
Corrosion kinetics is dependent on external factors such as temperature, solution 
concentration and velocity gradients that can impede the corrosion process [105]. 
 The spontaneity of a metal to oxidize (to form oxides) is dependent on its free 
energy of oxide formation. For Ti, Ta, Ni and Cr elements, the free energy of pure oxides 
and the reactions involved are as follows: 
               Ti + O2  TiO2                     ∆G = - 208.3 kcal/mol                    (3.8) 
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        Ti + 2H2O  TiO2 + 4H+ + 4e-            ∆G = - 82.92 kcal/mol                    (3.9) 
         Ni + O2  NiO2                      ∆G = - 55.45 kcal/mol                   (3.10) 
         2 Cr + 3/2 O2  Cr2O3                     ∆G = - 268.88 kcal/mol [108]          (3.11) 
        2 Ta + 5/2 O2  Ta2O5                       ∆G = - 509.56 kcal/mol [109]         (3.12) 
 According to Cabrera et al. [110] and Fehlenr et al. [111], from an atomic point of 
view, oxides form on the surface of a metal due to adsorption of oxygen atoms. This 
leads to formation of a thin oxide layer on its surface and results in a potential difference 
across the surface. This potential difference further promotes the diffusion of oxygen ions 
(anions) towards titanium present in the bulk of the alloy and results in the increase of 
oxide layer thickness. Since the oxide layer is formed mainly due to mobility of anions, 
this layer acts as an N-type semiconductor [111]. This process ceases when the thick 
oxide layer results in higher activation energy for oxygen ion transport across the film. In 
the presence of an externally applied potential difference to this metal, the anions will 
overcome the increased activation barrier and continue to form more oxide.  
3.2 Types of corrosion 
Metallic implants after implantation are subjected to various types of corrosion 
[105] due to highly corrosive and complex physiological environment consisting of 
water, dissolved oxygen, proteins, minerals, chloride and hydrogen ions, etc., that can 
eventually lead to corrosion. Corrosion of implants will cause their premature failure and 
release toxic corrosion by products that results in adverse biological and tissue responses. 
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3.2.1 Uniform corrosion  
Corrosion occurs all over the exposed metal’s surface at a uniform rate and 
involves reduction of metal to metal oxides and hydroxides. This type of corrosion is 
feasible when the corrosive electrolyte is accessible to all parts of a metallurgically 
homogenous metallic surface.  
3.2.2 Pitting corrosion 
 Pitting corrosion occurs when the potential of a passive protective film on a metal 
exceeds its breakdown potential. This leads to formation of a pit, where active dissolution 
of metal occurs and acts as an anodic site, whereas the undamaged passive oxide film 
behaves as a cathodic site. In general, pitting corrosion occurs on metals and alloys, 
relying on a passive surface film for their corrosion resistance in environments containing 
halides, e.g. Cl- [112]. This corrosion arises due to access of so-called aggressive anions 
[113]. It involves the formation of a local anode separated from the cathode where 
electrochemical reactions take place. At the cathodic site, i.e. the passivated surface, 
cathodic reactions occur, and at the anodic site, i.e. the “pit,” anodic reactions take place. 
The metal or alloy is the conductor for electrons moving between the sites. Metallic and 
non-metallic inclusions often play a decisive role in the initiation of pitting corrosion. As 
mentioned above, the presence of aggressive anions is necessary for breakdown of 
passivity and stable pit growth [113].  
 However, due to the harsh physiological environment present inside the human 
body, Nitinol implants are known to undergo pitting and crevice corrosion [38], as shown 
in Figure 3.1.  
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Figure 3.1: Occurrence of pitting corrosion on Nitinol in the presence of the complex 
physiological environment that prevails inside a human body. 
 The other factors that influence pitting corrosion of Nitinol are pH and 
temperature. Trepanier et al. [114] [115] has shown that an increase in temperature 
during corrosion of Nitinol will not affect its overall corrosion rate, but its ability to 
repassivate after breakdown of the oxide layer will be reduced. Additionally, an increase 
in pH resulted in no change in corrosion resistance of Nitinol, but it resulted in lowering 
its oxygen reduction potential [116].  
3.2.3 Crevice corrosion 
 Crevice corrosion occurs in regions of restricted flow, i.e. limited mass transport, 
resulting in exhaustion of reactants, e.g. dissolved oxygen [113]. The oxygen depletion 
and the accumulation of corrosion products lead to formation of a small concentration 
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cell, which enhances the anodic reaction (corrosion) inside the crevice. In the case of 
Nitinol, implantation of multiple overlapping stents to treat long vascular lesions (which 
arise in the Superior Femoral Artery), might create gaps (crevices) between the two 
stents, which can act as crevices and eventually lead to crevice corrosion [114]. ASTM 
F746 standard is used to determine the in-vitro crevice corrosion of overlapped stents. 
3.2.4 Fretting corrosion/erosion corrosion 
 When two metallic implants, such as stents or bone implants, are in contact and 
constant motion with respect to each other, surface wear occurs due to shearing forces. 
This leads to disruption of protective oxide layers or drug eluting coatings on implants 
and exposes the underlying material to fretting corrosion. In the case of multiple 
overlapping stents, fretting corrosion was observed in locations such as crossing points of 
the braided stent wires.  
3.2.5 Stress induced cracking corrosion 
 In general, stress corrosion cracking (SSC) is feasible with a combination of three 
factors: a tensile stress, a susceptible material, and a particular environment (fluorides 
and chlorides, or very low pH) [117]. After implantation, stents, bone, hip and dental 
implants are under constant stress applied by the surroundings. This stress leads to the 
formation of microscopic crack tips, which act as cathodic sites for corrosion initiation. 
Generation of hydrogen and vacancies due to these localized anodic and cathodic 
dissolution reactions at the crack tip will cause the material to transform from a ductile to 
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a brittle nature [118]. As a result, these cracks steadily grow deep into the material and 
lead to mechanical failure of implants.  
 Xiaoji li, et al.[119] has showed that the presence of high fluoride content in 
human oral environment will accelerate the crack initiation at the surface of Nitinol 
orthodontic wires and leads to SSC.  
3.2.6 Galvanic corrosion 
 When two dissimilar metals (a noble and an active metal) are in contact with each 
other in the presence of an electrolyte (a corrosive environment that acts as a closed 
electrical circuit), a preferential dissolution of active metal (anodic reaction), as 
compared with more noble metal (cathodic reaction), occurs [120-122]. Venugopalan et 
al. [123] showed that negligible galvanic corrosion occurred when passivated Nitinol is 
coupled with Ta. Whereas, an increase in the corrosion rate of Nitinol alloy by two orders 
of magnitude was observed when coupled with noble metals, such as, Platinum and gold-
palladium alloys [123]. 
 3.2.7 Intergranular corrosion 
 Intergranular corrosion occurs when the composition of the material within a 
grain and at its grain boundary is sufficiently different to create a variation in corrosion 
rates at these locations. In the case of surgical grade 316 SS, precipitation of chromium 
carbides will lead to chromium grain boundary depletion, and it leads to intergranular 
corrosion. However, reduction of carbon content (< 0.03%) or addition of elements such 
as Ti and Ta to surgical grade 316 has been shown to reduce this corrosion [124].   
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3.3 Methods to determine corrosion rate 
Corrosion resistance of implantable materials is a very important factor that 
affects their overall biocompatibility. Device implantation will always lead to some 
extent of inflammation and wound healing near the implantation site, which prompts the 
inflammatory cells to release super oxide and hydrogen peroxide molecules, as shown in 
Equation 3.13. This hydrogen peroxide is known to act as a corrosive agent for implanted 
materials [125, 126]. 
   (3.13) 
 The presence of proteins such as albumin and fibrinogen in the simulated body 
fluid will increase the in-vitro corrosion rates of implant materials[127]. There are mainly 
two different ways to determine corrosion rates. The first method consists of weight loss 
measurements and the second method consists of electrochemical characterization 
techniques, which include potentiodynamic and voltammetry studies. 
3.3.1 Potentiodynamic corrosion studies 
 Corrosion behavior of a metal over a wide range of oxidizing conditions can be 
understood by observing its polarization behavior. A polarization curve is a plot of the 
current from the working electrode’s surface versus the electrochemical potential applied 
to the electrode [107].  
 A metal immersed in electrolyte is said to be polarized when it is forced to deviate 
from its equilibrium potential (E0) or rest potential (Er). A potentiostat is used to either 
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vary the potential of a working electrode as a function of time with respect to a standard 
reference electrode or maintain it at a constant value and simultaneously measure its 
current as a function of potential. A potentiostat connected to a three electrode corrosion 
cell (working electrode, counter electrode and reference electrode) is used to measure the 
resulting current between the working and counter electrode.  
 During potentiodynamic corrosion studies, the potential across the working 
electrode is changed continuously at a constant scan rate (for example, 1 mV/min) and its 
corresponding response current is measured. Potentiodynamic corrosion tests provide 
important information regarding a metal’s ability to passivate in a given medium; 
stability of the passive oxide layer over a given range of potential; and corrosion rate 
[107]. Potentiodynamic polarization test produce log I vs. E curve, from which the 
polarization resistance (Rp), i.e., slope of dE/dI at corrosion potential is determined. The 
current measured during potentiodynamic corrosion indicates the rate of corrosion at a 
given potential.  
In general, the polarization curve of a metal consists of two sections, the anodic 
curve and cathodic curve, as shown in Figure 3.2. Based on the Tafel plot analysis, the 
cathodic or anodic current at the cross section of extrapolated portions of cathodic and 
anodic curves, represents the corrosion current (Icorr). Tafel analysis considers that, the 
rates of both the anodic and cathodic reactions are controlled by the kinetics of the 
electron transfer reaction at the metal/electrolyte interface surface. Stern-Geary equation 
and Tafel plot analysis parameters were used to determine Icorr value, as shown in 
Equation 3.14 [128]. 
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Icorr = βa βc / 2.3 Rp (βa + βc)  (3.14) 
Where, βa is the anodic Beta Tafel constant in volts/decade, βc is the cathodic Beta 
Tafel constant in volts/decade, Rp is the polarization resistance in volts. 
 
Figure 3.2: Potentiodynamic curve with anodic, cathodic curves and a Tafel plot to 
determine the corrosion current Icorr. 
In general, the polarization curve of a metal’s anodic dissolution consists of three 
different stages: (see schematic diagram in Figure 3.3) the active, passive and 
transpassive stages [129, 130]. In the active region or active metallic dissolution stage, an 
increase in the anodic potential leads to an increase in the corrosion current. This happens 
due to corrosion of metal, since the potential of the metal is less noble than the applied 
potential. 
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Figure 3.3: General anodic dissolution curve for an active passive metal [131]. 
 As the applied potential increases from the active to passive region, the metal is at 
a more noble potential due to the formation of a passive film on its surface and results in 
the reduction of the corrosion current. Once a thick passive layer is formed, the change in 
corrosion current becomes negligible with respect to the potential change. Generally, the 
difference between the corrosion current in the active and passive regions is very 
significant. In the transpassive region, when the applied potential reaches a very high 
value, once again the dissolution of metal ions takes place because of breakdown of the 
passive layer [129].  
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3.3.2 Calculation of corrosion rate 
 Corrosion rate (CR) of a metal under simulated electrochemical conditions can be 
determined by Faraday’s law [128] as shown in Equation 3.15. Icorr obtained by Tafel plot 
analysis is inserted into this equation to obtain a corrosion rate value. 
CR = K Icorr EW / A ρ		 	  (3.15) 
 Where CR is the penetration rate (mm/yr or mpy), K is a constant that defines the 
units for the corrosion rate, EW is the equivalent weight in grams/equivalent, ρ is density 
in grams/cm3, Icorr is the corrosion current in milli amps, A is the surface area of the metal 
that undergoes corrosion in cm2. 
Figure 3.4: Potentiodynamic curves for NiTi5Cr alloys 
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Figure 3.5: Potentiodynamic curves for NiTi10Ta alloys 
Figures 3.4 and 3.5 depict the potentiodynamic curves of MP, MEP and MEP + 
PC NiTi5Cr and NiTi10Ta alloys respectively. The Tafel plot and corrosion rate (CR) 
parameters of MP, MEP and MEP + PC Nitinol samples, obtained from potentiodynamic 
polarization curves are tabulated as shown in Table 3. 
Table 3.1: Tafel and corrosion rate parameters of MP, MEP and MEP + PC Nitinol 
samples 
Alloy βa (V/decade) βc (V/decade) Icorr (mA) CR (mpy) 
MP NiTi5Cr 1.65E+00 3.36E-01 5.20E-04 3.80E-01 
MEP NiTi5Cr 7.35E-01 2.37E-01 1.03E-04 9.43E-02 
MEP + PC NiTi5Cr 5.55E-01 2.77E-01 1.75E-05 1.27E-02 
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Table 3.1: Tafel and corrosion rate parameters of MP, MEP and MEP + PC Nitinol 
samples (continued) 
MP NiTi10Ta 1.09E+00 2.06E-01 1.47E-04 1.35E-01 
MEP NiTi10Ta 7.44E-01 2.36E-01 9.62E-05 8.81E-02 
MEP + PC NiTi10Ta 1.11E+00 4.35E-01 6.79E-05 4.79E-02 
A comparison of corrosion rates (Table 3.1) for different surface treated alloys 
shows that, the application of a polymer coating on MEP treated Nitinol resulted in a 
reduction of the corrosion rates. In the case of NiTi5Cr, the corrosion rate of MEP + PC 
NiTi5Cr (1.27E-2 mpy) was reduced by 10 times as compared with that of MP NiTi5Cr 
(3.80E-1 mpy). In the case of NiTi10Ta, the corrosion resistance of MEP + PC NiTi10Ta 
(4.79E-2 mpy) was less than that of MP NiTi10Ta (1.35E-1 mpy). The typical corrosion 
rates for bare Nitinol have been elsewhere reported in the range of 0.1 – 2.26 µm/y 
[132],[133]. 
3.3.3 Cyclic potentiodynamic polarization tests 
 A cyclic potentiodynamic polarization curve is obtained when the electrochemical 
behavior of a metal is studied under a controlled potential. The potential initially starts at 
a value below or equal to the metal’s rest potential and proceeds in a forward direction 
until it reaches a potential value in its transpassive region. Then, it is reversed until it 
reaches a value below its repassivation potential [129, 134].  
39 
 
                   
Figure 3.6: a) & b) Typical cyclic potentiodynamic curves illustrating different corrosion 
parameters [129]. 
 As the potential reaches the breakdown potential (Eb) in the forward direction of 
the scan, the passive oxide layer (steady state surface structure) will start disrupting with 
an increase in potential. This leads to an increase in corrosion current, as shown in Figure 
3.6.a. As per ASTM f 2129-08, the difference between Eb and Er indicates the resistance 
to pitting corrosion for a given metallic material. Later, when the direction of scanning 
potential is reversed, the curve forms a loop in a clockwise direction and meets the 
forward scan at a potential called repassivation potential (Ep). At this potential, the steady 
state surface structure is restored and no localized corrosion occurs below this potential. 
The hysteresis formed in the cyclic potentiodynamic polarization curve, as shown in 
Figure 3.6 a, is caused by the current density difference produced between the forward 
and reverse portions of the scan at a given potential. It denotes the ease or difficulty with 
which that initial structure is restored as the scanning potential reaches Ep [135]. As the 
area of the hysteresis loop increases, the disruption of surface passivity (occurrence of 
localized corrosion) increases with a higher difficulty in restoring a passive surface [136]. 
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The severity of crevice corrosion susceptibility increases with increasing hysteresis of the 
polarization curve, which is the difference between Eb and Ep. Figure 3. 6. b corresponds 
to the cyclic potentiodynamic polarization curve of a material with anti-clockwise loop or 
no hysteresis. It happens when the reverse anodic curve is shifted to a lower current 
density before the scanning potential crosses the breakdown potential [137]. This 
suggests that no pitting corrosion occurs during the reverse anodic portion of the cyclic 
potentiodynamic curve [138] and these type of material are highly resistant to localized 
corrosion [137, 139]. 
  The general anodic dissolution curve for an active passive metal described in 
Section 3.3.1 serves as a fundamental example to study the cyclic polarization curves of 
Nitinol alloys. In the present research, in-vitro cyclic potentiodynamic polarization tests 
were conducted as per the ASTM F2129 – 08 [129] standard on MP, MEP and polymer-
coated Nitinol alloys to determine their susceptibility to pitting and crevice corrosion. 
This standard is generally used to determine the corrosion susceptibility of small implant 
devices.  
3.3.4 Cyclic potentiodynamic polarization curves 
The cyclic potentiodynamic polarization curves for each surface treated ternary 
Nitinol was plotted against its MP alloy’s curve for comparative analysis. Figure 3.7 and 
3.8 show the cyclic potentiodynamic polarization curves of MP, MEP, MEP +PC Nitinol 
alloys. 
It was observed that the MP NiTi10Ta had a lower resistance to localized 
corrosion when compared with that of MEP, MEP +PC NiTi10Ta alloy (Fig. 3.7). 
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NiTi10Ta displayed a positive hysteresis loop which is an indicative of susceptibility to 
pitting corrosion [140]. 
 
Figure 3.7: Cyclic potentiodynamic polarization curves for NiTi10Ta alloys 
As shown in Fig 3.8, NiTi5Cr displayed no hysteresis loop, which is a 
characteristic of an alloy that is highly resistant to localized corrosion. Additionally, the 
MP NiTi5Cr had a lower resistance to localized corrosion as compared with that of MEP, 
MEP +PC NiTi10Ta alloy. 
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Figure 3.8: Cyclic potentiodynamic polarization curves for NiTi5Cr alloys 
For metals with positive hysteresis loop, the difference between its Eb (break 
down potential) and Er (rest potential) during anodic dissolution serves as a measure of its 
resistance to pitting corrosion. In the case of metals with negative hysteresis loop, the 
vertex potential serves as a measure of its corrosion resistance. The average corrosion 
parameters, such as Eb, Er, Ep (protection potential), Ev (vertex potential) and Eb-Er 
(resistance to pitting corrosion) obtained during cyclic polarization tests for the 
aforementioned Nitinol alloys are given in Table 3.2.  
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Table 3.2: Cyclic potentiodynamic corrosion data for Nitinol alloys 
Alloy Eb (V) Er (V) Ep (V) Ev (V) Eb-Er (V) 
NiTi10Ta-MP 0.812 -0.434 0.634 - 1.246 
NiTi5Cr-MP -0.614 - 1.074 - 
NiTi10Ta-MEP 0.954 -0.548 0.791 - 1.502 
NiTi10Ta-MEP+ PC 1.146 -0.397 0.971 - 1.543 
NiTi5Cr-MEP 0.485 -0.473 - 0.825 - 
NiTi5Cr-MEP+PC 0.986 -0.467 - 1.73 - 
It can be observed that the resistance to pitting corrosion (Eb – Er) was high for 
MEP NiTi10Ta (1.502 mV) and MEP + PC NiTi10Ta (1.543 mV) as compared with that 
of MP NiTi10Ta (1.246 mV). This is attributed to the formation of protective oxide layer 
during MEP treatment on NiTi10Ta alloy. Additionally, the vertex potential (Ev) of MEP 
+ PC NiTi5Cr (1.73 mV) was high as compared with that of the MP NiTi5Cr (1.074 
mV). These results confirm that the polymer coating on MEP treated Nitinol alloys acts 
as a barrier and reduces the localized corrosion on their surfaces. 
3.4 Electrochemical impedance spectroscopy (EIS) 
 In electrochemical impedance spectroscopy (EIS), the response of an electrode to 
alternating potential signals of varying frequency (AC voltage) is interpreted on the basis 
of circuit models of the electrode/electrolyte interface [104]. EIS was used to determine 
polarization resistance and to model the corrosion process by fitting impedance data with 
corresponding equivalent circuits (Fig. 3.9). The modeling procedure uses electrical 
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circuits built from components such as resistors and capacitors to represent the 
electrochemical behavior of the coating and the metal substrate. EIS is known to be very 
useful to evaluate electrochemical performance of coatings, batteries, etc. [141]. In the 
present research, EIS was used to study the corrosion properties of the biodegradable 
polymer-coated Nitinol alloys.  
 
Figure 3.9: Equivalent circuit model used to represent a simple electrochemical interface 
undergoing corrosion in the absence of diffusion control. Rs – Solution resistance, Rp – 
polarization resistance, Cdl – capacitance of double layer 
 In EIS, the impedance of the corroding metal (working electrode) due to an 
applied sinusoidal potential change (AC voltage) is analyzed as a function of frequency 
ω. At each frequency, the resulting sinusoidal current waveform and the applied potential 
are out of phase by phase angle (θ), whereas the current amplitude is inversely 
proportional to the impedance of the interface [104]. The electrochemical impedance, Z 
(ω), is the frequency-dependent proportionality factor in the relationship between the 
voltage signal and the current response, 
Z (ω) = E (ω) / i (ω)                                         (3.13) 
 where E is the voltage signal, E = E0 sin (ω t); i is the current density, i = i0 sin (ω 
t + θ); Z is the impedance (ohm - cm2); and t is the time (seconds) [142]. 
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 Impedance is a complex number that is described by the frequency-dependent 
modulus, |Z|, and the phase angle, θ, or, alternatively, by the real component, Z′, and the 
imaginary component, Z″ [104]. In electrochemical impedance analysis, three different 
types of plots are commonly used. Figure 3.10 depicts the Nyquist plot which shows 
complex plane Z″ vs. Z′ and the capacitive arc provides an estimate of corrosion 
resistance of the material, in terms of its relative diameter, which is directly proportional 
to the charge transfer resistance or polarization resistance (Rp). Thus, an increase in 
semicircle diameter corresponds to an increase in corrosion resistance [127].  
 
Figure 3.10: A typical Nyquist plot that depicts the real and imaginary impedance values, 
on the X and Y- axis, respectively, for the aforementioned equivalent circuit.   
Figure 3.11 depicts the two different Bode plots, showing the impedance 
magnitude (log Z) vs. log frequency (log f) and the phase angle vs. log frequency [104]. 
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Figure 3.11: A typical Bode plot that shows log frequency on the x-axis, and both the 
absolute value of the impedance Log Z and phase-shift θ on the y-axis [143] for the 
aforementioned equivalent circuit. 
Since real electrochemical processes hardly show pure capacitance, during EIS 
analysis, the non-ideal response of the corrosion system is represented by a CPE to obtain 
accurate impedance values [144-146]. Bryan H et al. [147] has shown that CPE behavior 
can be attributed to the distribution of physical properties of coatings in a direction 
normal to the electrode’s (substrate) surface. Systems with a CPE element have a Nyquist 
plot that consists of an arc of a circle with the center somewhere below the x-axis instead 
of a semicircle, as shown in Figure 3.10. Geometric distributions, such as surface 
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inhomogenities [148] and porosity of the electrode [149], are known to lead to CPE 
behavior in EIS measurements.  
The two general equivalent circuit models used to represent the bare and polymer 
coated Nitinol alloys in this research are shown in Figure 3.12.a and 3.12.b, respectively. 
 
 
Figure 3.12 a) Equivalent circuit of a bare Nitinol alloy, b) Equivalent circuit of a Nitinol 
alloy with a polymer coating 
Parameter Rp, coupled with Qs or CPEs (s - substrate), represent the processes that 
occur at the substrate layer (at the electrolyte/substrate layer interface). Rpore corresponds 
to the charge transfer resistance associated with the penetration of the electrolyte through 
the pores or pinholes that exist in the external coating and Rp is the polarization resistance 
at the electrolyte/substrate interface in the pores. Qc corresponds to capacitance of the 
coating layer and Qs to the capacitance at the electrolyte/substrate interface, which seems 
to be associated with the double layer formation [150, 151]. Rsol is the ohmic resistance 
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of the electrolyte. The impedance of a constant phase element (CPE) Q is given by 
Equation 3.14 [152]: 
 Q = ZCPE = (1/Y0)/ (jω)n  (3.14) 
 where Y0 corresponds to the admittance of the electrode, j is the imaginary 
number (j = √(-1)), ω is the angular frequency (ω = 2Πf and f is the frequency) and n 
(0~1) is an exponential term, which is related to the slope of the log (Zmod) vs. log f in 
Bode plot [150]. CPE has the unit Ss^n (Siemens-second^n). CPE is a mathematical 
construct that characterizes the response of a process with a constant phase shift over a 
large frequency range. In Equation 3.14, when n = 1, CPE behaves as a pure capacitor 
and when n = 0, CPE behaves as a resistor [150].  
3.4.1 EIS results 
The Nyquist and bode plots for different surface treated NiTi10Ta and NiTi5Cr 
alloys were as shown in Figures 3.13 to 3.18. 
 
Figure 3.13: A comparative Bode plot analysis for different surface treated NiTi5Cr  
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alloys 
 
Figure 3.14: A comparative Bode plot analysis for different surface treated NiTi15Cr 
alloys 
 
Figure 3.15: A comparative Nyquist plot analysis for different surface treated NiTi5Cr 
alloys  
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Figure 3.16: A comparative Bode plot analysis for  different surface treated NiTi10Ta 
alloys 
 
Figure 3.17: A comparative Bode plot analysis for different surface treated NiTi10Ta 
alloys 
51 
 
 
Figure 3.18: A comparative Nyquist plot analysis for different surface treated NiTi10Ta 
alloys 
A variation in the polarization resistance (Rp) of a metal due to the change in its 
surface properties can be observed in terms of its Nyquist and Bode plots as shown in 
Figure 3.19. An increase in Rp value of a metal signifies an improvement in its corrosion 
resistance ie., the diameter of the arc in the Nyquist plot increases and even the 
magnitude of the impedance (ǀZǀ) increases towards a lower frequency in the Bode plot. 
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Figure 3.19: Effect of changing Rp in terms of illustrative a) Nyquist plot; b) & c) Bode 
plots 
The value of the reaction resistance Rpore is characteristic of the corrosion 
resistance of the polymer coatings and is worth comparing to determine the relative 
protective effect of each polymer [120]. 
In this research, Bode and Nyquist plots obtained for surface coated and uncoated 
Nitinol alloys were analyzed using appropriate equivalent circuit models. 
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Table 3.3: Significance of different equivalent elements used in an equivalent 
circuit  
Symbol Equivalent element Admittance Impedance 
 Resistor (R) 1/R R 
 Capacitor (C) JωC 1/ jωC 
 
Constant Phase Element (Q) Y0 (jω)n (1/Y0)/ (jω)n 
  
 Table 3.3 depicts the impedance and admittance values of different equivalent 
elements used in an equivalent circuit. 
The EIS curves for both polymer coated and uncoated Nitinol alloys were fitted 
into their respective equivalent circuits to determine their EIS coating parameters, such 
as, Rsol and Rp. The equivalents circuits and their corresponding coating parameters for 
aforementioned ternary Nitinol alloys are shown below. 
 
 
Figure 3.20: a) Equivalent EIS circuit for MEP Nitinol alloys, b) schematic of 
corresponding metal – metal oxide - electrolyte interface 
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Table 3.4: EIS fitted parameters for MEP Nitinol alloys (mean ± SD, n=5) 
Parameter RSol (Ω) Rp (Ω) YS (S*s^a) aS 
NiTi10Ta – MEP 876±4 1.51e6±6.4e4 18.8e-6±10.2e-8 936.2e-3±2.08e-3 
NiTi5Cr – MEP 1.07e3±5 2.46e6±7.4e4 8.3e-6±4.5e-8 943.2e-3±1.88e-3 
 
where Rsol, the testing solution resistance, is in series with a parallel circuit consisting of 
Rp and Ys, the reaction resistance associated with interfacial charge transfer reaction 
process and capacitance associated with the electrolyte double layer established at the 
interface, respectively [120]. 
  
 
Figure 3.21: a) Equivalent EIS circuit for a two-layer model: MEP + PC Nitinol alloys, b) 
schematic of corresponding metal/metal oxide/polymer/electrolyte interface 
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Table 3.5: EIS fitted parameters for MEP + PC Nitinol alloys (mean ± SD, n=5) 
Parameter RSol (Ω) Rpore (Ω) RP (Ω) YC 
(S*s^a) 
aC YS  
(S*s^a) 
aS 
NiTi10Ta 
MEP + PC 
771±26 5.3e6±4.
3e5 
280±50 7.5e-6± 
51.2e-9 
898.7e-
3±3.1e-3 
117.1e-
6±1.4e-6 
431.7e-
3±143.2e
-3 
NiTi5Cr 
MEP + PC 
114±31 13.8e6±
3.8e5 
24.6e3±8
2 
5.49e-6± 
84.9e-9 
775.4e-
3±8.9e-3 
107.0e-
6±75.3e-6 
174.6e-
3±69.9e-
3 
 
From Table 3.5 it can be observed that Rpore and Rp of MEP + PC NiTi5Cr were 
high as compared with that of MEP + PC NiTi10Ta alloy. This shows that the polymer 
coating on MEP + PC NiTi5Cr has a better corrosion resistance than MEP + PC 
NiTi10Ta alloy. 
3.5 Methodology for cyclic polarization and EIS tests 
A Gammry corrosion cell, as shown in Figure 3.22, was used to perform the 
corrosion tests. 
 
Figure 3.22: Gamry corrosion cell kit used for cyclic potentiodynamic polarization tests. 
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1- Standard reference calomel electrode, 2 - Working electrode (PNT), 3 - Counter 
electrode (Carbon rod), 4 - Lugging capillary, 5 - N2 gas inlet , 6 - N2 gas outlet , 7 - 
Sample holder. 
Deionized water was used to rinse the corrosion cell before performing the tests. 
The cell with the PBS electrolyte was brought up to 37 ºC by placing it in a 
thermostatically controlled temperature water bath. A saturated calomel electrode was 
inserted into the Luggin capillary. The surface area of the pellet in contact with PBS was 
carefully calculated in order to increase the accuracy of the corrosion parameters. The 
PBS solution was purged with ultra-high purity nitrogen for 30 minutes, prior to 
immersion of the pellet. Later, the working electrode that was immersed in the electrolyte 
was subjected to nitrogen purging for an additional 30 minutes, before starting the cyclic 
polarization tests, at which stage the rest potential was obtained. A GAMRY® 
potentiostat (G-750) was employed with a scan rate of 1 mV/s over a potential range of -
0.1 to 3.0 vs. a Saturated Calomel Electrode (SCE).  
EIS tests were conducted in a specially developed EIS cell, as shown in Figure 
3.23.  
 
Figure 3.23: EIS cell with counter, reference and working electrodes 
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 EIS tests were conducted in accordance with ASTM G 3-89 at 37 °C, employing a 
GAMRY® potentiostat (G-750). PBS was purged with high-purity nitrogen for 30 
minutes prior to conducting the EIS tests to remove any dissolved oxygen. The 
experiment was conducted in a frequency range from 1.0-2 Hz to 1.0+5 Hz with 10 points 
per decade. The evolution of impedance spectra is presented as a Bode plot from which 
the magnitude of polarization resistance and characteristic corrosion behavior are seen. 
3.6 Nickel ion leaching 
 The regular standard dietary intake of Ni in the human body is about 150-900 
µg/day [153]. The concentration of Ni ions in human blood varies from 25–67 ppb [154]. 
Arndt et al. [155] showed that the amount of Ni ions leached from orthodontic Nitinol 
wires under in-suit conditions varied between 0.2 to 0.7 µg cm-2. Depending on the 
surface preparation and surface composition of Ni in Nitinol, Ni leaching will vary [156]. 
Shabalovskaya et al. [157] observed that, based on the type of  Nitinol’s surface 
finishing, Ni ion leaching has varied from 0.03 mg/ml to 1.8 mg/ml and it occurred even 
after five months of implantation. For example, formation of a thick external TiO2 layer 
during high-temperature annealing of Nitinol in air leads to accumulation of Ni in the 
sub-surface layers and this can act as a reservoir for Ni leaching when the surface oxide is 
damaged [156]. Shabalovskaya et al. [157] described that, since nickel has a smaller 
atomic radius as compared with titanium and oxygen atoms, and also due to the 
spontaneous formation of non-stoichiometric titanium oxide layers (oxygen vacancy 
defects), formation of Ni-rich reservoirs (interstitial atomic defects) in the intermediate 
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layers will occur. This leads to Ni diffusion through the oxygen vacancies after 
implantation of Nitinol, as shown in Figure 3.24. 
 
Figure 3.24: Formation of non-stoichiometric titanium oxide layer and Ni-rich 
intermediate layers on Nitinol. 
 The rate of metal ion transfer through the passive oxide film and its stability 
against dissolution will control Ni leaching [158]. According to Haider et al. [39], the 
concentration of Ni released from Nitinol after 24 hours of immersion in phosphate 
buffer saline solution under static and dynamic conditions range between 12.4 and 23.4 
µg/L. Systemic accumulation of Ni ions takes place mainly in the kidneys and lungs of 
the human body [159]. In addition, the presence of Ni ions in the human body poses 
problems for the immune, cardiovascular, blood, and respiratory systems [160]. 
Furthermore, nickel compounds, such as NixSy, NixSey, and NixAsy (x and y are integers) 
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act as carcinogenic agents [161], which could result in the formation of tumors. As 
leaching of Ni is a surface-related phenomenon, in the case of bone implants such as 
porous Nitinol (PNT), due to its large surface area-to-volume ratio, higher Ni ion release 
can be expected [41, 162, 163]. In the case of self-expanding cardiovascular stents 
prepared from Nitinol, Ni leaching was believed to promote neointimal proliferation[42]. 
Additionally, Ni leaching is dependent on other factors, such as surface roughness, 
thickness of surface oxide layer, its composition, bulk composition and presence of non-
equiatomic chemical species on its surface (Ti2Ni, Ni3Ti, and Ni) [164]. Oxidation, 
water boiling, passivation, dry heating, electropolishing and magneto electropolishing of 
Nitinol were some of the surface treatments that were known to improve the 
aforementioned properties of the passivating oxide layer, and can lead to variation in 
surface Ni concentrations [162] [114] and reduced Ni leaching [165]. Michiardi et al. 
[166] demonstrated that oxidation of Nitinol in O2 at a pressure of 3 x 10-2 mbar at 400 
°C for 2 hours and 30 minutes can lead to a Ni-free TiO2 surface. Surface characteristics, 
such as morphology, roughness [167-169], surface energy [169], corrosion resistance, 
and surface layer chemical composition [170, 171], play an important role in the 
interaction between Nitinol implants and cellular adhesion and their proliferation in the 
human body [167, 172]. As a result, surface treatment of Nitinol before implantation can 
be employed to modify its chemical, physical, and biological interaction properties [173].  
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CHAPTER 4 
MATERIALS AND METHODS 
4.1 Ternary Nitinol alloys 
 Cylindrical ingots of ternary Nitinol alloys NiTi5Cr and NiTi10Ta (atomic %) 
were prepared by arc melting (AM) at the National Institute of Standards and Technology 
(NIST). The compositions of these alloys in at% are shown in Table 4.1.  
Table 4.1: Ternary Nitinol alloys composition in atomic percentages 
Nickel Titanium Chromium Tantalum 
48.45 46.45 5 - 
45.90 44.10 - 10 
 Experimental samples were prepared by cutting the cylindrical ingots with a high-
speed linear precision saw (ISOMET 4000) into cylindrical discs of dimension (10mm x 
2mm).  
4.1.1 Alloying of Nitinol 
 Tantalum (Ta) alloys are recognized for their promising in-vivo biocompatibility 
[174, 175] and bioactivity [176] due to their excellent corrosion resistance [177], low 
toxicity, good osteointegration and mechanical properties. Porous Ta alloys and Ta 
coatings have been studied for bone implant applications [178]. Tantalum acts as a radio-
opaque [125] material, since its high density (16.654 g/cm3) resist the passage of x-rays. 
Jinalu et al. [179] showed that addition of Ta to Nitinol improved the alloy’s x-ray 
visibility (subject contrast). Since Nitinol alloys have very low x-ray visibility, usage of 
Ta and its oxides as markers [180, 181] in implants (stents, cardiac defibrillators, etc.) 
enable surgeons to track them during and after implantation procedures. 
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 The addition of chromium (Cr) is known to create a corrosion resistant and 
passive oxide layer on the surface of Nitinol alloy. This happens due to a greater affinity 
of Cr for oxygen rather than chloride ions as discussed by Horvath and Uhlig [182]. 
Additionally, Cr is known to increase the yield stress, stiffness and torqueability of 
Nitinol alloy [183]. 
4.2 Biodegradable polymer 
In this investigation, a biodegradable co-polymer consisting of 
polycaprolactone (PCL)/poly glycolic acid (PGA) in the ratio of 90/10 was used as a 
coating. The properties of each constituent polymer are shown in Table 4.2.  
Table 4.2: Physical and chemical properties of PGA [184] and PCL [185] polymers 
PGA PCL 
Poly (glycolide) – linear aliphatic polyester Poly (ɛ - caprolactone) 
Monomer – glycolide Monomer – e caprolactone 
Ring opening polymerization of glycolide 
yields high molecular weight materials 
Ring opening polymerization of e – 
caprolactone 
Crystalline (45%-55%) Semi crystalline 
Melting temperature,Tm = 220-225 ⁰C Tm = 59-64 ⁰C 
Glass transition temperature, Tg = 35-40 ⁰C Tg = -65 to -60 ⁰C 
Degradation time 6-12 months Degradation time > 24 months 
Elastic modulus, 6.0-7.0 GPa 0.21-0.44 GPa 
Tensile strength, 60-99.7 MPa 20.7-42 MPa 
Tensile elongation, 1.5-20 (%) 300-1000 
PGA synthesis 
 
PCL synthesis 
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4.2.1 Degradation of biosorbable polymers  
 A biomaterial is defined as a material intended to interface with biological 
systems to evaluate, treat, augment or replace any tissue, organ or function of the body 
[23]. A polymer is defined as a non-metallic solid material with high molecular weight 
[186]. Polymers generally consist of a single or multiple monomer units depending on 
their nature and repeat themselves to form a high molecular weight substance. In general, 
polymers used for biomedical applications can be broadly categorized into biodegradable 
and non-biodegradable polymers. The word ‘biodegradable’ itself suggests that these 
polymers, both in in-vitro and in-vivo conditions, will degrade into either normal 
metabolites or degradation products that could be completely eliminated from the body 
without further transformations [187-189].  
Biodegradable polymers when placed in a complex biological environment, such 
as that prevailing inside a human body, will dissolve by a combination of two processes, 
namely degradation and erosion [187, 188]. They undergo degradation through a chain 
scission process in which long polymer chains will be broken down into small oligomers 
and then eventually into single monomer units either hydrolytically or enzymatically 
[190]. Hydrolytic degradation of a polymer is dependent on many factors, such as its 
molecular weight, type of chemical bond, pH, co-polymer composition and mainly its 
hydrophilicity or hydrophobicity [187]. Hydrophilic polymer coatings were shown to 
display lower levels of monocyte adhesion (an indicator of platelet adhesion) as 
compared with hydrophobic polymer coatings. The addition of pH varying compounds to 
the polymer matrix will also affect its degradation rate [187]. The erosion of polymers 
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occurs due to dissolution and diffusion of the aforementioned low molecular weight 
polymer products by the liquids in contact with them [187, 188, 191]. Erosion process 
can occur by two different methods namely, surface erosion and bulk erosion [187]. 
During surface erosion, only the surface layers of a polymer matrix undergo erosion and 
results in a predictable drug release kinetics [187] [191]. Bulk erosion is not limited to the 
surface of the polymer matrix but the bulk of the polymer erodes and it results in a 
diffusion dependent drug release [187] [191]. Additionally, during bulk erosion the shape 
of the polymer is retained before its degradation [192]. Figure 4.1(a) shows surface 
erosion of a polymer matrix and its layer by layer drug release pattern, and Figure 4.1(b) 
shows bulk erosion of polymer matrix and its bulk drug release pattern. Although, PGA 
and PCL belong to the polyester group, PCL’s structure differs from PGA by two extra 
carbon atoms in its polymer’s backbone. PCL has a lower in-vivo biodegradation rate as 
compared to PGA and so it is applied for more controlled drug release applications [193].   
 
Figure 4.1 a) Surface erosion and b) bulk erosion in polymer matrix 
Polylactic acid (PLA), polyglycolic acid (PGA) and the copolymer polylactic-co-
glycolic acid (PLGA) are some of the biodegradable polymers that are widely used for 
medical applications, such as sutures, orthopedic and drug eluting devices [194, 195]. 
Both PGA and PCL are known to degrade by bulk erosion process. The aforementioned 
biodegradable polymers when used as DES coatings will ensure the gradual release of the 
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drug due to hydrolytic degradation of their ester bonds [196]. Subsequently, enzymatic 
degradation of lactic and glycolic acids will result in production of water and carbon 
dioxide [197]. The physiochemical properties of a polymer coating, such as cross linked 
density, water content, isoelectric point and molecular weight between cross links should 
be considered while tailoring the stent coating for drug delivery [198]. The degradation 
rate of PGA/PCL polymer can be controlled by varying the composition and molecular 
weight of its corresponding monomers. 
4.3 Magneto-electropolishing treatment 
Magneto-electropolishing (MEP) is known to increase the hydrophilicity and 
fatigue resistance of implant materials, in addition to improve oxide formation and 
corrosion resistance [199]. In the case of stainless steel, MEP has resulted in improved 
surface hydrophilicity as compared with that of electropolished surfaces. Hydrophilicity 
plays a major role in improved biocompatibility of implant materials [40]. Tadeusz et. al., 
[200] showed that MEP treatment of SS 316L has not only enhanced its corrosion 
resistance, wettability, surface energy and cleanability, but also reduced its external 
surface soiling and micro roughness. Therefore, MEP treatment can be applied to medical 
implantable devices, such as stents and intravenous vascular devices, to improve their 
overall biocompatibility by enhancing their surface chemistry and morphology.  
The magnetoelectropolishing (MEP) process utilizes an externally applied 
uniform magnetic field below 500 mT (produced by a neodymium ring) around an 
electrolytic cell to achieve a smooth surface with improved and uniform corrosion 
resistance. The strength of the external magnetic field applied to the electrode controls its 
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electrochemical reaction either by increasing or decreasing the dissolution rate (which is 
independent on the composition of dissolved metal and the electrolyte) [200]. When MEP 
is conducted below the oxygen evolution regime, it not only prevents hydrogen 
absorption but also removes residual hydrogen from the metal. Additionally, the quality 
of MEP treatment is dependent on parameters such as duration of the process, voltage 
level, type of electrolyte and its temperature.  
  In general, every metallic surface has irregularities in its surface layer (1-100 nm), 
which consists of foreign materials, metallic and non-metallic inclusions and a layer of 
pre-existing oxides that is also known as a beilby layer (formed either due to machining 
or processing) [201]. In the initial stages of MEP treatment on Nitinol, this beilby layer 
will be removed from its surface. A Lorentz force (a cross product of a magnetic field 
and current) is created by the externally applied magnetic field during MEP treatment 
(performed at fixed potential and below the oxygen evolution regime or plateau region) 
and this rotates the electrolyte around the axis in a direction parallel to that of the 
magnetic field [202]. The circular motion of the electrolyte causes a reduction in the 
thickness of the diffusion layer (viscous layer) due to increased mass transport and this 
eventually speeds up the dissolution process. An opposite effect is observed when MEP is 
conducted at a fixed-potential and beyond the plateau current densities in the oxygen 
evolution regime [202]. Kim, et al. [203] mentioned that the usage of a magnetic field 
during electropolishing activates the electrolyzed ions by the Lorenz force, which 
eventually leads to electrolysis. This is followed by the formation of a uniform and dense 
TiO2 oxide layer, which improves corrosion resistance. 
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4.4 Dip coating 
 Initially, the polymer was dissolved in CCl4 solvent to obtain a 5 (w/v) % solution 
and then it was applied as a thin coating on the MEP treated ternary Nitinol alloys using a 
dip coating method. A schematic of the dip coating technique used to polymer coat the 
alloys is illustrated in Figure 4.2, where a linear motion stage was used to move the 
sample in and out of the dipping suspension.  
 
Figure 4.2: Schematic of dip coating setup. 
 The thickness of the polymer coating was controlled by varying the dipping time. 
Later, these samples were dried at 40 ⁰C (a temperature just below the glass transition 
temperature of the co-polymer) in vacuum (10 mbar) for 24 hours to obtain a  polymer 
coating that is intact and free of any remnant solvent.  
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CHAPTER 5 
BIOCOMPATIBILITY STUDIES 
5.1 Restenosis 
Prior to 1980s, atherosclerosis (hardening of coronary arteries due to the gradual 
deposition of lipid and cholesterol plaques on the inner layer, or intima of the arteries) 
was treated using balloon angioplasty. But at times, this process was known to damage 
the inner lining wall of arteries exposing the extracellular matrix. This damage leads to 
neointimal hyperplasia, which is an immune system's reaction to the disruption of an 
artery wall. The exposed extracellular matrix triggers the hyper-proliferation of smooth 
muscle cells into the intima, where they cluster and form a lesion. As a result, a thick scar 
tissue developed form at this location, which eventually lead to arterial blockage and 
obstructed flow is known as restenosis. Within 3 to 6 months after balloon angioplasty, at 
least 40-50% of patients suffered from restenosis. As a result, stents were introduced into 
the market in order to overcome the incidence of restenosis.  
5.2 Thrombosis 
Thrombosis (~0.5 to 0.8 episodes/year/patient) is the primary cause of vascular 
access failure in dialysis patients [204, 205]. At least 41% of the central venous catheters 
(CVC), which play a major role in oncology, urology and general medicine, result in 
thrombotic occlusion of blood vessels [206]. In general, implants with surfaces in contact 
with blood flow can initiate activation, secretion, adherence, aggregation of platelets and 
trigger subsequent plasmatic coagulation, and immunological responses, depending on 
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the material’s hemocompatibility [207]. Spreading of platelets and “opening” of their 
integrin receptors such as, αIIbβ3 (fibrinogen receptor) and α2β1 (collagen receptor) will 
lead to platelet aggregation [208, 209]. Indeed, blood contacting devices are prone to 
clotting and inflammatory responses, which impair their performance and can be 
detrimental to patients. For example, the migration of thrombus to vasculature within the 
brain may lead to stroke and in some cases, even death.  
During and immediately following stent implantation, disruption of the 
endothelial layer can trigger the adhesion of proteins, such as fibrinogen, fibronectin, 
vitronectin, immunoglobulin and von Willebrand factor (vWF) (a blood glycoprotein) 
onto the newly exposed sub-endothelial layer. This ultimately leads to activation, 
adhesion and deposition of platelets [207, 210, 211], and subsequently to thrombus 
formation. In the case of a biomaterial, when it is exposed to blood, a rapid adsorption of 
plasma proteins will occur. Adsorption of higher amounts of fibrinogen on the surface of 
biomaterial renders increased thrombogenicity, whereas adsorption of higher amounts of 
albumin convert it into a hemo-compatible surface [212]. An ideal biomaterial used for 
cardiovascular implants is expected to withstand such thrombus formation as well as 
inflammatory host responses at least until a de novo superficial endothelial layer is 
formed. In the case of metallic implant materials, properties such as surface free energy, 
surface charge [213-215], roughness, wettability, surface composition (oxide layer, 
functional groups) [216], metal ion leaching and corrosion resistance ultimately affect 
their interaction with the surrounding blood proteins, platelets and extracellular material 
[217, 218]. 
69 
 
 In the case of cardiovascular stents, thrombogenicity is dependent on intrinsic 
properties such as corrosion resistance, hemocompatibility and mechanical dexterity. 
However, the extrinsic properties of a stent, such as its dimensions, design, combination 
of the drug and polymer coating affect its thrombogenicity via platelet activation [22, 
219-222]. Additionally, its placement relative to the vessel wall, which imposes specific 
flow disruptions such as stagnation and recirculation, also has a similar effect. Activation 
is immediate and reaches a maximum state approximately 2 to 4 hours following 
implantation of the device [223].  
5.3 Cytotoxicity of biomaterials 
 In addition to the high risk of thrombus formation, additional problems associated 
with stents on the market include leaching of metal ions, (e.g. Ni, Co and Cr), which can 
lead to carcinogenic [224] and allergic reactions [225] as well as restenosis [226], 
inflammation and activation of platelets [227, 228]. As a result, there is still an urgent 
need for cardiovascular implant materials that are more hemo and biocompatible. In the 
case of Nitinol, in addition to its surface properties, alloying and surface treatment 
directly regulate the material’s hemo and biocompatibility [229-231]. For example, the 
addition of Cr, a highly passivating element to Nitinol, has been reported to enhance 
hemocompatibility [232], corrosion resistance and endothelial cell proliferation [233]. 
5.3.2 Inductively coupled plasma mass spectroscopic analysis 
The corrosion liquids obtained during in-vitro corrosion tests of polymer-coated 
and un-coated Nitinol alloys were subjected to inductively coupled plasma mass 
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spectroscopic (ICPMS) (ELAN-DRC-ICPMS, Perkin-Elmer, Waltham, Massachusetts) 
analysis to determine the extent of dissolved metal ion content under the following 
acquisition parameters of ICP RF power 1225: nebulizer gas flow 0.94 L/min, plasma gas 
flow 16 L/min and lens voltage 8.75 V. Each sample was analyzed in 3 replicates by ICP-
MS analysis. The average values of 3 replicates along with the standard deviation error 
bar are shown in Figures 5.3 to 5.8. 
The average concentration of dissolved metal ions (Ni, Cr, Ti and Ta) in the PBS 
electrolyte after corrosion tests of Nitinol alloys is displayed in Table 5.1. The 
concentration of Cr ions eluted from NiTi5Cr alloys was reduced by MEP treatment and 
application of polymer coating. Concentration of Ta and Ti ions eluted into PBS from 
Nitinol alloys during corrosion tests was below the detectable levels of the ICPMS. 
Table 5.1: ICPMS analysis of Cr and Ni ions leached from the surface of Nitinol alloys 
Material 
Cr (µg/L) Ni (µg/L) Ti 
(µg/L) 
Ta 
(µg/L)Avg SD Avg SD 
MP NiTi5Cr 92.7 1.52 30.7 2.92 ND ND 
MP NiTi10Ta ND - 31.2 3.45 ND ND 
MEP NiTi5Cr 68.2* 8.9 4.7* 0.95 ND ND 
MEP NiTi10Ta ND - 18.5 4.16 ND ND 
MEP + PC NiTi5Cr 11.4* 2.92 1.2* 0.12 ND ND 
MEP + PC NiTi10Ta ND - 22.1 3.98 ND ND 
MP NiTia ND - 69.9 0.35 ND ND 
Note: * refers top < 0.05 in one-way ANOVA analysis, n=3 and a-correspond to 
reference [59] 
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The amount of ions such as, Ni, and Cr eluted into PBS during potentiodynamic 
corrosion studies of Nitinol alloys are presented in Figures 5.1 and 5.2 respectively.
 
Figure 5.1: ICPMS results showing the concentration of Ni ions in the corrosion liquids 
obtained from different surface treated Nitinol alloys; * refers to p < 0.05 in one-way 
ANOVA analysis 
ICPMS results as shown in Figure 5.1 indicate the effect of surface treatments and 
alloying on Ni ion leaching from Nitinol alloys. Haider et al.[59] mentioned that the 
amount of Ni ions leached during potentiodynamic corrosion of mechanically polished 
binary Nitinol was 69.9 µg/L. From the current study, ICPMS analysis revealed that the 
amount of Ni ions released from MP NiTi5Cr (30.7 µg/L) and MP NiTi10Ta (31.2 µg/L) 
was less as compared with that of MP NiTi.  
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In the case of NiTi5Cr alloy, MEP treatment has tremendously reduced the Ni ion 
leaching from its surface (4.7µg/L). This reduction in Ni ion leaching from MEP NiTi5Cr 
can be attributed to the formation of a protective oxide layer on its surface during MEP 
treatment. The increase in the intensity of NiO peak observed during XRD analysis of 
MEP NiTi5Cr alloys (Chapter 6) can be attributed to lower Ni ion release. Additionally, 
MEP + PC NiTi5Cr (1.2 µg/L) showed the lowest amount of Ni ions leached as 
compared with the rest of the alloys. One way ANOVA analysis of the ICPMS analysis 
revealed that the amount of Ni leached from MEP and MEP +PC NiTi5Cr was 
significantly low (p < 0.05) as compared with that of MP NiTi5Cr. This reduction in Ni 
ion leaching can be directly correlated to the reduced corrosion rate of MEP + PC and 
MEP NiTi5Cr as compared with that of MP NiTi5Cr. Although a slight reduction in Ni 
ion leaching was observed in MEP NiTi10Ta (24.85 µg/L), as compared with the MP 
NiTi10Ta (31.2 µg/L) and MEP + PC NiTi10Ta (30.87 µg/L), it was statistically 
insignificant. 
 
Figure 5.2: ICPMS results showing the concentration of Cr ions in the corrosion liquids 
obtained from different surface treated NiTi5Cr alloys; * refers to p < 0.05 in one-way 
ANOVA analysis 
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Figure 5.2 indicates that the amount of Cr ions leached from NiTi5Cr samples has 
reduced after MEP treatment (68.2 µg/L) as compared with MP NiTi5Cr (92.7 µg/L). 
Furthermore, application of polymer coating on MEP NiTi5Cr has substantially reduced 
the Cr ion elution (11.4 µg/L) during corrosion tests. One-way ANOVA analysis revealed 
that the Cr ions leached from each group of surface treated NiTi5Cr was significantly 
different from each other. 
5.4 Sulforhodamine B (SRB) assay 
 SRB assay serve as a simple, effective and reproducible cytotoxic test to 
determine the growth of an adherent cell line101 in a given toxic environment. The basic 
principle of this method involves the absorption of a negatively charged dye called 
sulphorhodamine B (SRB) by the amino acids present in the living cells [234]. In these 
experiments, live endothelial cells stay attached to the well plate and these will absorb the 
SRB dye. During the experiment, the optical density of the absorbed dye is directly 
proportional to the cell density. Additionally, in this method, the results were observed to 
be linear over a 20-fold range of cell number [234]. This technique was inexpensive and 
productive, especially when a large number and a wide variety of samples are to be tested 
in a limited period. 
5.4.1 Cell culturing and media for SRB assay 
 Human Primary Umbilical Vein Endothelial Cells - HUVEC (ATCC® PCS-100-
010™), obtained in a frozen state, were thawed to room temperature before culturing 
them. The cell culture media as recommended by the ATCC company was prepared by 
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thawing and mixing one  Endothelial Cell Growth Kit-VEGF (ATCC® PCS-100-041™) 
into one bottle of Vascular Cell Basal Medium (ATCC® PCS-100-030™) under aseptic 
conditions. The cells along with cell culture media were placed in a 75cm2 flask and 
incubated at 37 ⁰C at 5% CO2. The cell culture medium was changed in the flask after 
every 48 hours to remove the dead cells and provide sufficient nutrients for the existing 
cells. Once the cells reached confluency in the cell culture flask, approximately after 7 to 
8 days, they were tripsinized. These cells were utilized in subsequent cytotoxicity and 
cell growth tests. 
5.4.2 Cytotoxicity assay (SRB assay) protocol 
 A sulforhodamine B (SRB) assay (In Vitro Toxicology Assay Kit, 
Sulforhodamine B based-TOX6, Sigma-Aldrich, Saint Louis, MO) was conducted to 
assess cell proliferation in the presence of the Ni ions leached during corrosion tests. 
1. A 96 well-plate was used for seeding the human umbilical vein endothelial cells 
(HUVEC), in which 200 μL of cell suspension of optimum density (20,000 cells/well 
or 1 x 105 cells/ml) was used in each well. 
2. The PBS solution obtained from the corrosion tests of different samples, namely MP 
NiTi10Ta, MP NiTi5Cr, MEP NiTi10Ta, MEP NiTi5Cr, MEP + PC NiTi10Ta and 
MEP + PC NiTi5Cr, were filtered using a 0.2 micron filter, and the final solution for 
the cytotoxicity test was made by adding 10% Fetal Bovine Serum, 1% penicillin and 
0.3mg/L G418 powder. This was referred to as the corrosion electrolyte. 
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3. After 24 hours of incubation, the cell culture media in the wells was removed and 
replaced by various proportions of cell culture media and corrosion electrolyte to 
produce the following: 10% corrosion electrolyte and 90% cell culture media; 50% 
corrosion electrolyte and 50% cell culture media; 100% corrosion electrolyte; and 
finally with 100% cell culture media as a control.  
4. HUVEC cells incubated in 100% cell culture medium were considered as the control 
samples for SRB studies. 
5. At the end of the 48-hour incubation period, 50 μL of cold (4 °C) 50% TCA was 
added to 200 µL of the liquid already present in each well. 
6. The well plates were left at room temperature for 30 minutes for the HUVEC cells to 
be fixed to the well plates. 
7. TCA was removed from the wells and the well plate was rinsed using tap water at 
least 5 times and allowed to dry overnight. 
8. 100 μL of 0.4% (w/v) sulforhodamine B (SRB) dissolved in 1% acetic acid solution 
was added to the wells (staining of the cells). The greater the number of endothelial 
cells, the greater the amount of SRB dye (negatively charged pink color 
aminoxanthine dye) bound to the amino acids of endothelial cells [235]. The wells 
were then placed in the incubator for 30 minutes. 
9. After the staining period, the wells were rinsed with 1% v/v acetic acid at least 4 
times to remove the unbound SRB dye and then allowed to dry. 
10.  200 μL of 10mM Trizma Base solution was added into each well to solubilize the 
bound SRB dye. 
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11. The fluorescence of the viable cells was determined by placing the 96 well plate into 
a multiplate reader (TECAN GENios multiplate reader,Tecan, Männedorf, Schweiz) 
to obtain SRB readings of absorbance.  
12. Before obtaining the readings, the well plate was shaken for 5 minutes, by the plate 
reader, followed by the data analysis. 
13. Additionally, these SRB assays were repeated on the aforementioned liquids, for 
duration of 4 and 7 days, to determine the prolonged effects of these corrosion liquids 
on HUVEC cells. 
14. Absorbance values were subsequently presented in the form of normalized cell 
proliferation values with respect to a negative control (absorbance of cells grown in 
cell culture media alone).  
5.4.3 Cytotoxicity data 
Figures 5.3 to 5.8 illustrate the cytotoxic behavior of corrosion extracts obtained 
from in-vitro potentiodynamic analysis of different surface treated ternary Nitinol alloys 
in PBS at 37 °C. All samples exhibited a gradual increase in cell growth in extracts of 
10%, 50% and 100% over periods of 2, 4 and 7 days. SRB assay on the corrosion liquids 
obtained from different surface treated Nitinol samples is as follows: 
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Figure 5.3: Net growth rate of HUVEC cells after 2 days of exposure to leached ions 
from potentiodynamic corrosion tests of different surface treated NiTi5Cr (mean ± SD, n 
= 3); * refers to p < 0.05 in one-way ANOVA analysis. 
 
 
Figure 5.4: Net growth rate of HUVEC cells after 4 days of exposure to leached ions 
from different surface treated NiTi5Cr during potentiodynamic corrosion tests (mean ± 
SD, n = 3); * refers to p < 0.05 in one-way ANOVA analysis. 
*
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Figure 5.5: Net growth rate of HUVEC cells after 7 days of exposure to leached ions 
from different surface treated NiTi5Cr during potentiodynamic corrosion tests (mean ± 
SD, n = 3); * refers to p < 0.05 in one-way ANOVA analysis. 
 
 
Figure 5.6: Net growth rate of HUVEC cells after 2 days of exposure to leached ions 
from different surface treated NiTi10Ta during potentiodynamic corrosion tests (mean ± 
SD, n = 3). 
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Figure 5.7: Net growth rate of HUVEC cells after 4 days of exposure to leached ions 
from different surface treated NiTi10Ta during potentiodynamic corrosion tests (mean ± 
SD, n = 3). 
 
Figure 5.8: Net growth rate of HUVEC cells after 7 days of exposure to leached ions 
from different surface treated NiTi10Ta during potentiodynamic corrosion tests (mean ± 
SD, n = 3). 
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Cytotoxicity of 100% and 50% corrosion liquid extracts from different surface 
treated NiTi5Cr alloys on HUVEC cells after 2, 4 and 7 days show that, cell viability in 
MEP NiTi5Cr and MEP + PC NiTi5Cr groups were significantly high (p < 0.05) as 
compared with that of MP NiTi5Cr group. These results are supported by ICP-MS 
analysis (Figure 5.3), where the concentration of Ni in the MEP and MEP + PC NiTi5Cr 
extracts was at least 1 order of magnitude lower than that in MP NiTi5Cr. The 
statistically low amount of Cr ions leached from MEP and MEP + PC NiTi5Cr (Figure 
5.4), during corrosion tests can be considered as an additional factor for increased cell 
viability in SRB assays.  
In the case of SRB values for different surface treated NiTi10Ta alloys, no 
significant difference (p > 0.05) in cell viability between MP NiTi10Ta, MEP NiTi10Ta 
and MEP + PC NiTi10Ta was observed at 10%, 50% and 100% corrosion extracts after 
2, 4 and 7 days duration (Figures 5.6 to 5.8). This corroborates with the amount of Ni 
ions leached from different surface treated NiTi10Ta alloys during potentiodynamic 
corrosion tests (Figure 5.3). 
5.5 Endothelial cell growth 
 MP, MEP and MEP + PC Nitinol alloys were seeded with 50×103 HUVECs per 
well (placed into a 24-well plate) and were subsequently immersed in cell culture media 
and incubated for 48 hours in a controlled environment at 37 ºC, 5% CO2 and 95% air, 
i.e., standard incubator conditions. After the incubation period of 48 hours, the cell 
culture media in the wells was removed and the samples were gently washed with DPBS 
four times to remove the dead cells and cell culture media. Three test samples for each 
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type of material were used for cell growth analysis. Then, the samples were fixed in 70% 
ethanol at 2⁰C for 6 hours and then dried in a desiccator for 24 hours. Later, they were 
gold-sputter coated to be observed under Scanning Electron Microscopy (SEM - JEOL 
JSM 6330F) at a low vacuum of 5KV, 110X magnification and SEI mode. 
5.5.1 Cell growth on metallic and polymer coated samples 
 Cell behavior, such as adhesion, cell division and differentiation, is influenced by 
the surface properties of an implant. Consequently, integration and tolerance of an 
implant in the body are decisively influenced by the surface properties of the materials 
used. HUVEC cell growth on MEP + polymer-coated samples and MP Nitinol samples 
were observed using SEM, as shown in Figures 5.9 and 5.10. 
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Figure 5.9: SEM photomicrographs of HUVEC cell growth on a) MP NiTi10Ta, b) MPE 
NiTi10Ta, c) MEP + PC NTi10Ta and d) A comparative analysis on polymer-coated and 
uncoated MEP NiTi10Ta alloy. 
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Figure 5.10: SEM photomicrographs of HUVEC cell growth on a) MP NiTi5Cr, b) MPE 
NiTi5Cr, c) MEP + PC NiTi5Cr and d) A comparative analysis on polymer-coated and 
uncoated MEP NiTi5Cr alloy. 
 By qualitative observation and comparison of cell growth on both the alloys, it 
was apparent that HUVEC cell growth on various surfaces was as follows:  
MEP NiTi10Ta / MEP + PC NiTi10Ta > MP NiTi10Ta > MEP NiTi5Cr / MEP + 
PC NiTi5Cr > MP NiTi5Cr. 
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Figure 5.9 shows SEM photomicrographs of confluent HUVEC cell growth on 
both PGA/PCL polymer-coated and bare MEP alloys, as compared with that of MP 
Nitinol alloys. The density of cell growth on MEP alloys was high, compared with that of 
MP alloys, which can be attributed to the improved surface topography, wettability and 
composition of MEP alloys. In the case of PGA/PCL co-polymeric coatings [236], cell 
growth is dependent on its crystallinity, composition, and topography. The presence of a 
monolayer of HUVEC cells, with extended fillopodia after 48 hours of incubation, 
indicates that the co-polymeric coating was conducive for cell growth. Helen et al. 
showed improved osteoblast cell growth on PGA/PCL (65/25) co-polymer with increased 
concentration of PGA monomer [236] [237]. Additionally, molecular weight of the 
polymer has been reported to affect cell growth, protein adhesion and its degradation 
rates [236]. 
5.6 Platelet adhesion test 
 A custom-built, multi-specimen, laminar flow chamber was used to investigate 
the adhesion of blood components on implant materials (Figure 5.11a).  
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Figure 5.11: (a) Schematic of a closed-loop system for platelet adhesion studies, (b) Five 
flow chambers connected in a parallel circuit to the main inlet and outlet paths, (c) The 
dynamic flow chamber for platelet adhesion studies.  
5.6.1 Materials for platelet adhesion test  
 MP NiTi10Ta, MP NiTi5Cr, MEP NiTi10Ta, MEP NiTi5Cr, MEP + PC 
NiTi10Ta and MEP + PC NiTi5Cr were used as the experimental samples to determine 
their platelet adhesion properties. Additionally, mechanically polished (MP) stainless 
steel (SS) (Online Metals, Seattle, WA) and binary Nitinol (NiTi) (NDC Alloys Inc. 
Fermont, CA) of dimensions ~ 2cm X 2cm X 0.5 mm were studied for comparative 
analysis. The aforementioned alloys were mechanically polished (MP) using three 
different waterproof silicon carbide papers (MSC Industrial Supply, #s 320, 1200 and 
4000  Melville, NY) applied in the order of increasing grit size, using a plate grinder (Cat 
# 78156056, MSC Industrial Supply, Melville, NY) at 30 rpm for 10 minutes for each 
paper. Each of the eight test samples was placed in a recessed cavity within five flow 
chambers (Figure 5.11b). The flow loop for platelet adhesion studies consisted of a 
peristaltic pump to drive blood flow, silicon tubes to connect the flow chambers, a blood 
reservoir and a water bath to maintain the temperature of whole blood at 37 ⁰C (Figure 
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5.11c). The velocity of blood flow was maintained at 113 cm/s, which is within the 
dynamic range of velocities measured in the veins of the upper limbs [238]. Prior to 
hemocompatibility testing, metallic samples (MP and MEP) were ultrasonically cleaned 
for 5 minutes in DI water, followed by cleaning in 70% ethanol for 5 minutes to eliminate 
impurities and foreign particles on the surface. The polymer-coated samples were 
sterilized by exposing them to UV radiation for 40 minutes, before conducting the 
platelet adhesion tests. Once all the samples were placed in the chambers of the flow loop 
(n = 5 samples at a time), a phosphate buffer saline (PBS) solution was used to prime the 
loop for 10 minutes. Approximately 500 ml of freshly collected whole porcine blood 
(Mary’s Ranch Inc., Miami, FL) was mixed with 150 ml of sodium citrate anticoagulant. 
333.5 ml of 10 mM mepacrine dye solution was added for every 500 ml of whole porcine 
blood to fluorescently label the platelets [239]. The blood was passed over the metallic 
samples in the loop for 35 minutes. After each run, samples were extracted and carefully 
washed with PBS three times to remove any residual blood components. Platelets that 
adhered on to the samples were observed under a fluorescent microscope (Nikon Eclipse 
E 200, Nikon, Melville, NY). The number of platelets adhered on each sample were 
counted carefully using an image analysis software (Image J, NIH, Bethesda, MD).  
5.6.2 Statistical analysis 
 A statistical analysis was performed on platelet adhesion data using a one-way 
ANOVA analysis, followed by post-hoc testing (Tukey HSD). The 8 type of materials 
subjected to the testing were SS, NiTi, MP NiTi5Cr, MP NiTi10Ta, MEP NiTi5Cr, MEP 
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NiTi10Ta, MEP + PC NiTi5Cr and MEP + PC NiTi10Ta. A significant difference 
between materials was interpreted to occur at p < 0.05.  
5.6.3 Platelet adhesion results 
 Blood clotting on a foreign implant surface is still a complex mechanism which 
has to be thoroughly investigated before further understanding is accomplished. Platelet 
adhesion and aggregation are controlled by the composition of the surface oxide film on a 
metal due to its relative permittivity (electrostatic forces), which influences the amount of 
adsorbed proteins [240]. Data collected from platelet adhesion studies include the 
fluorescent images of platelets adhered to various surfaces.   
In this investigation, platelets adhered on the aforementioned metallic samples 
during platelet adhesion tests were observed under SEM as shown in Figure 5.12. 
 
Figure 5.12: SEM photomicrograph of platelets adhered MEP NiTi5Cr (a) 1000 X and 
(b) 3300X 
Figure 5.12 shows that platelets adhered on MEP NiTi5Cr were in the stages of 
discoid shape (no pseudopodia) to early dendritic shape (one or more pseudopodia with 
no evident flattening) after 35 minutes of blood on the metal’s surface [241]. 
88 
 
Fluorescent images of platelets adhered to different surface treated metallic alloys 
are shown in Figure. 5.13. 
 
 
 
Figure 5.13: Fluorescent microscopic images of porcine platelets adhered to various 
alloys a) MP NiTi, b) MP SS, c) MP NiTi5Cr, d) MP NiTi10Ta, e) MEP NiTi5Cr, f) 
MEP NiTi10Ta g) MEP + PC NiTi5Cr and h) MEP + PC NiTi10Ta. 
 Platelet adhesion tests revealed that the highest number of platelets (platelets 
adhered /mm2) was found on the SS surfaces, followed by MP Nitinol alloys and MEP 
Nitinol alloys and next, on MEP +PC Nitinol alloys (Figure 5.14).  
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Figure 5.14: Porcine platelets adhered to the surface of different alloys; NiTi - Nitinol, SS 
- stainless steel, NiTi5Cr and NiTi10Ta – ternary Nitinol alloys, MP - mechanically 
polished, MEP – magneto electropolished (n=5, mean ± SD) ; * p < 0.05 indicates values 
are significantly different from MP alloys. 
 A one-way ANOVA analysis followed by a post-hoc test (Tukey HSD) of platelet 
adherence values revealed that MEP + PC ternary Nitinol alloys were the least 
thrombogenic (P < 0.05) in comparison to all the other MP alloys (Figure 5.14). 
5.6.4 Correlation between platelet adhesion and surface free energy 
Figure 5.15 depicts a reduction in platelet adhesion on various surfaces with an 
increase in interfacial free energy. These results indicate that thrombogenicity is reduced 
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with an increase in interfacial free energy of a material as was reported by Rokicki et 
al.[242].  
 
Figure 5.15 Correlation between the number of platelets adhered and interfacial free 
energy (n = 5, mean ± SD). 
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CHAPTER 6 
SURFACE CHARACTERIZATION 
6.1 Surface morphology by scanning electron microscopy (SEM) analysis 
  Scanning Electron Microscopy (SEM) was used to determine the morphologies of 
MP, MEP and MEP + PC Nitinol alloys. The Nitinol samples were studied using a JEOL 
JSM-5900 Low Vacuum SEM. SEM provides both qualitative and quantitative data 
regarding the morphology of Nitinol alloys. Two types of images were obtained in this 
study namely, secondary electron image (SEI) and back scattered electron image (BEI). 
6.1.1 Secondary electron image (SEI)  
 This image is produced when the high energy electron beam from the tungsten 
filament of the SEM hits the weakly bound electrons of the outer layer atoms of the 
specimen, resulting in their ejection from the atoms. This results in the formation of a 
SEI, which produces a clear and detailed picture of the materials surface morphology. 
6.1.2 Back scattered electron image (BEI) 
 When the high energy SEM electron beam hits the nucleus of the atoms on the 
surface of the specimen they become scattered back. These electrons are recorded as the 
BEI. The samples with higher atomic number will produce more back scattered electrons. 
This helps in the determination of the different species present on the specimen surface.    
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6.2 Energy dispersive X-ray spectroscopy (EDS) 
 Energy Dispersive X-Ray Spectroscopy (EDS) works in conjunction with SEM to 
study the elemental distribution and microanalysis on the surface of a given material. In 
this method a high energy electron beam was utilized to excite the atoms of a metal to 
higher energy states in order to produce the characteristic X-rays from them. The X-rays 
produced were peculiar for each and every element and thereby used to study the 
different elements present in a given specimen.               
           
Figure 6.1: SEM photomicrographs/EDS analysis of MP NiTi5Cr 
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Figure 6.2: SEM photomicrographs/EDS analysis of MEP NiTi5Cr 
 
Application of MEP treatment to mechanically polished (MP) ternary Nitinol 
alloys has resulted in a change in their surface morphology, topography and chemistry. 
Figure 6.1 and 6.2 are SEM/EDS photomicrographs of NiTi5Cr before and after MEP 
treatment. These figures reveal that MEP resulted in depletion of Ni and Ti metal and 
enrichment of Cr at the grain boundaries, whereas, MEP treatment on NiTi10Ta resulted 
in depletion of metal within the grain as compared to the grain boundary. As a result, 
opposing variations in surface chemistry and morphology were observed at the grain 
boundaries of both alloys.  
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Figure 6.3: SEM photomicrograph of a) MEP + PC NiTi5Cr, inset view is b) 
MEP NiTi5Cr 
 
 
Figure 6.4: SEM photomicrographs/EDS analysis of MP NiTi10Ta 
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Figure 6.5: SEM photomicrographs/EDS analysis of MEP NiTi10Ta 
 
Figure 6.6: SEM photomicrographs of  MEP NiTi10Ta a) 2000X BEI image, b) inset 
view at 6000X BEI image  
SEM/EDS analysis of MP and MEP NiTi10Ta indicated the presence of high 
amounts of Ta in dendritic structures at grain boundaries due to grain boundary 
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segregation that occurred during processing of the material as shown in Figures 6.4 and 
6.5. Similar tantalum segregation was observed by Olson [243] when Ta was used in 
ferrous shape memory alloys. When NiTi10Ta was observed under BEI mode using 
SEM, the NiTi matrix appeared as greyish due to its low molecular weight and Ta 
appeared bright due to its higher molecular weight. From Figure 6.6, it can be observed 
that within each grain of NiTi10Ta, Ta was visible as a dispersed secondary phase. 
Additionally, the 3D topography of MEP treated NiTi10Ta and NiTi5Cr were 
observed using a Phenom Tabletop SEM. Figure 6.7 indicated that, during MEP, the 
grain area of NiTi10Ta was preferentially depressed (valley) with respect to the grain 
boundaries leading to raised grain boundaries (crests). In the case of NiTi5Cr, MEP 
treatment has resulted in opposite morphology, where the grains became the crest and the 
depletion occurred along the grain boundaries forming the valleys (Figure 6.8).  
 
Figure 6.7: Phenom SEM photomicrographs of MEP NiTi10Ta a) at grain b) at grain 
boundary 
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Figure 6.8: Phenom SEM photomicrographs of MEP NiTi5Cr, a) at grain b) at grain 
boundary 
6.3 Roughness of Nitinol alloys and polymer coating thickness by optical 
profilometer  
The roughness of different surface treated Nitinol alloys was determined using a 
Nanovea optical profilometer.   
 
Figure 6.9: Roughness of surface treated and untreated ternary Nitinol alloys (n = 3, mean 
± SD) 
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The roughness data was analyzed using a Scanning Probe Image Processor (SPIP) 
and the average roughness (Ra) values were plotted in Figure 6.9. A slight reduction in 
roughness was observed for MEP NiTi5Cr (Ra = 350 ±116 nm) as compared with that of 
MP NiTi5Cr (Ra = 540 ± 150 nm). No significant difference in surface roughness was 
observed before and after application of polymer coating on MEP Nitinol alloys.  
The thickness of the polymer coated samples was determined using an optical 
profilometer as shown in Figure 6.10. It was observed that the polymer coating thickness 
on MEP Nitinol alloys varied from 2.4 µm to 3.5 µm. 
 
Figure 6.10: Schematic of the thickness measurement using optical profilometer. 
Additionally, thickness measurements conducted by phenom tabletop SEM 
revealed a similar thickness in the range from 2.5 µm to 3.3 µm as shown in Figure 6.11. 
 
Figure 6.11: Phenom SEM image of thickness of a polymer coating 
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6.4 Morphology of polymer coated alloys before and after corrosion by SEM 
 The surface morphology of polymer coated alloys before and after corrosion tests 
were observed using a SEM to identify the effects of corrosion. 
 
Figure 6.12: SEM photomicrographs of the surface of PC + MEP NiTi10Ta, a) before 
corrosion and b) after corrosion    
 
Figure 6.13: SEM photomicrographs of the surface of PC + MEP NiTi5Cr a) before 
corrosion and b) after corrosion    
Small pores (~1 to 2µm in diameter) were observed on the surface of polymer 
coated NiTi10Ta alloys after potentiodynamic corrosion analysis (Figure 6.12). The 
corrosion of the underneath metal and the Ni ion dissolution from NiTi10Ta which were 
observed and discussed in chapters 3 and 5 respectively, can be attributed to the 
formation of these pores during corrosion. 
a) b) 
Pores 
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Figure 6.13 indicates that the surface morphology of the polymer coating on 
NiTi5Cr alloy did not change much after conducting corrosion tests on it. 
6.5 Surface chemistry of bare Nitinol alloys by XPS analysis 
The amount of Ti, Ni, Cr, Ta, their respective oxides and their thickness on the 
surfaces of the MEP Nitinol alloy samples were determined with a scanning X-ray photo 
electron spectroscopy (XPS) microprobe ( Minnesota)  using monochromatic Al Kα X-
ray radiation (sputter etch rate of 6.5 nm/min). A schematic of the XPS analysis is shown 
in Figure 6.14. 
6.5.1 Analytical Objectives 
1. Sputter profile to a depth where the composition of the major components stabilizes. 
2. Evaluate the XPS spectra to obtain chemical state information that may be available. 
 
Figure 6.14: Schematic diagram of XPS analysis  
6.5.2 Measurement Approach 
1.  Wide energy survey spectra were collected in a large area analysis mode to determine 
which elements were present at the surface using monochromatic Al Ka x-ray beam. 
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2.  Sputter depth profiles were obtained by using 1 kV argon ions rastered over a 1x1 mm 
area.  
6.5.3 Montage plots 
Titanium present on the surface of Nitinol is known to form a spontaneous 
titanium oxide layer. The titanium oxide is mainly composed of a tetravalent (Ti4+) Ti 
atom as shown in Ti montage plots. The intensity of the peaks for different species of Ti 
in the titanium oxide layer is dependent on the type of surface treatment that it underwent 
[59]. Montage plots are useful in classifying different chemical states of an element by 
identifying its corresponding binding energy peaks. Figures 6.15 and 6.16 correspond to 
the Ti montage plots for MEP NiTi10Ta and MEP NiTi5Cr respectively. Based on these 
montage plots, the surface of these alloys consists of a mixed oxide layer mainly 
composed of Ti0 (metallic) 2p3/2 peak at 454.0 eV and 2p1/2 peak at 460.5 eV; Ti 2+ (TiO) 
2p3/2 peak at 455.5 eV and 2p1/2 peak at 461.8 eV; and Ti4+ (TiO2) 2p3/2 peak at 458.4 eV 
and 2p1/2 peak at 464.5 eV.  
 
Figure 6.15: Deconvoluted montage plot for titanium Ti 2p spectra from a MEP 
NiTi10Ta surface; a - Ti metal, b – TiO oxide and c-TiO2 
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Figure 6.16: Deconvoluted montage plot for titanium Ti 2p spectra from a MEP NiTi5Cr 
surface; a - Ti metal, b – TiO oxide and c-TiO2 
Nickel present on the surface of Nitinol is known to exist in metallic (Ni0), NiO 
(Ni2+) and NiOH (Ni2+). The Ni montage plots in Figures 6.17 and 6.18 exhibited Ni0 and 
Ni2+ peaks on the surface of MEP NiTi10Ta and MEP NiTi5Cr respectively. Based on 
these montage plots, the surface of these alloys consisted of Ni0 (metallic) 2p3/2 peak at 
853.3 eV and Ni2+ (NiO and Ni(OH)2) 2p3/2 peak at 854.3 eV and 2p1/2 peak at 861.5 eV.  
 
Figure 6.17: Deconvoluted montage plot for titanium Ni 2p spectra from a MEP 
NiTi10Ta surface; a - Ni metal and b – NiO oxide  
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Figure 6.18: Deconvoluted montage plot for Nickel Ni 2p spectra from a MEP NiTi5Cr 
surface; a - Ni metal and b – NiO oxide  
 Figure 6.19 indicates the presense of tantalum on the surface of MEP NiTi10Ta 
alloy. These peaks at Ta 4f7/2 (23.2 eV), 4f5/2 (24.8 eV) and 5p3/2 (34.2 eV) correspond to 
metallic Ta. These results were consistent with those obtained by XRD (section 6.6) of 
MEP NiTi10Ta, which showed the presence of Ta on its surface. 
 
Figure 6.19: Montage plot of tantalum Ta 4f peak obtained for MEP NiTi10Ta surface. 
The Cr montage plot in Figure 6.20 exhibited Cr0 and Cr3+ peaks on the surface of 
MEP NiTi5Cr. Based on these montage plots, the surface of these alloys consisted of Cr0 
(metallic) 2p3/2 peak at 574.5 eV and 2p1/2 peak at 584.7eV; Cr3+ (Cr2O3) 2p3/2 peak at 
577.4 eV and 2p1/2 peak at 588.2 eV.  
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Figure 6.20: Montage plot for chromium Cr 2p spectra from MEP NiTi5Cr surface;  
a - Cr metal and b – Cr2O3 oxide  
A summary of all the XPS peaks observed on the surface of MEP ternary Nitinol 
alloys and their corresponding reference values are tabulated in Tables 6.1 and 6.2. 
Table 6.1: XPS binding energies for different elements present on the surface of MEP 
ternary Nitinol alloys [29, 244-247]. 
Type of species 
Experimental  values Reference values 
2p3/2 (eV) 2p1/2  (eV) 2p3/2 (eV) 2p1/2  (eV)
Ti0  (metallic) 454 460.5 454, 454.2, 454.5 460 
Ti 2+ (TiO) 455.5 461.8 455.1 462 
Ti 3+ (Ti2O3) NA NA 457.8 463.3 
Ti 4+ (TiO2) 458.4 464.5 458.4 464.6 
Cr0 (metallic) 574.5 584.7 574.4 583.6 
Cr2+ (Cr2O3) 577.4 588.2 577.5 587.5 
Ni0 (metallic) 853.3 NA 851.8,  852.6 858.3 
Ni 2+ (NiO) 854.3 861.5 853.7, 854.6 861.8 
Ni 3+ (Ni2O3) NA NA 856.3 , 856.1 
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Table 6.2: Ta element XPS peaks obtained on the surface of MEP NiTi10Ta. 
Type of 
species 
Experimental  values Reference values 
4f7/2 (eV) 4f5/2 (eV) 4f7/2 (eV) 4f5/2 (eV) 
Ta (metallic) 23.2 24.8 21.8 23.8 
Ta 5+ (Ta2O5) NA NA 26.2 29.2 
 
The amount of Ni, NiO and Ni(OH)2 present on the surface of MEP NiTi5Cr and 
MEP NiTi10Ta are shown in Table 6.3. These results indicated that the amount of 
metallic Ni and NiO present on the surface of MEP NiTi10Ta were double the amount 
that was present on MEP NiTi5Cr. This higher Ni content on the surface of MEP 
NiTi10Ta as compared with that on MEP NiTi5Cr, has led to higher Ni release from its 
surface during corrosion and this correlated with the ICPMS results (as shown in Figure 
5.1 and described in Chapter 5).  
Table 6.3: The amount (at%) of different species of Ni present on the surface of MEP 
NiTi5Cr and MEP NiTi10Ta 
Chemical species MEP NiTi5Cr MEP NiTi10Ta 
Ni 0.150 0.384 
NiO 0.133 0.371 
Ni(OH)2  0.716 0.245 
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Figure 6.21: Depth profile analysis obtained from the surface of MEP NiTi5Cr 
 Depth profile analysis of different elements present on the surface of MEP 
NiTi5Cr is shown in Figure 6.21.   
6.6 XRD analysis of surface oxides on Nitinol alloys  
 X-ray Diffractometer (XRD) analysis was conducted on MP and MEP treated 
ternary Nitinol alloys, in an effort to determine the presence of different metallic phases 
(martensite or austenite), types of oxides (such as TiO2, NiO, etc.) and metallic ions (Ni), 
which are known to affect their corrosion and bio-compatibility properties. The 
crystallinity of the oxide layers was determined using a Siemens D 500 XRD (Siemens, 
Munich, Germany). The XRD results for treated and untreated Nitinol are shown in 
Figure 6.22.  
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Figure 6.22: XRD analysis of MP NiTi, MEP NiTi5Cr and MEP NiTi10Ta. 
 Based on XRD analysis, nickel in its metallic form and titanium oxide (TiO2) in 
anatase form were found on the surface of MP NiTi. The presence of elemental Ni was 
detected on the surface of MP-NiTi and MEP NiTi5Cr. In addition to all the phases 
detected on MP NiTi, the MEP NiTi5Cr surface possessed a greater amount of nickel 
oxide and less elemental Ni. These results are comparable to the Ni and NiO 
concentrations provided by XPS analysis (Table 6.3). Whereas, nickel oxide (NiO), 
amorphous TiO2 (42) and β-Ta [179, 248] were observed on the surface of MEP 
NiTi10Ta (Figure 6.22). Additionally, it was observed that MP NiTi and MEP NiTi5Cr 
were austenitic phases, whereas MEP NiTi10Ta was martensitic. Similarly, Gong et al. 
[248] cited the presence of β-Ta and martensitic NiTi (Monoclinic B-19’) in the Ni-Ti-Ta 
108 
 
alloy system. The β-Ta is known for its high resistivity (180-220 µ.ohm.cm) and 
disordered structure[249]. Alloying and MEP treatment has resulted in the conversion of 
metallic Ni on the surface of Nitinol into NiO.  
6.7 Determination of mechanical properties of NiTi alloys by Nano-indentation  
 The bulk hardness and Young’s modulus of elasticity were determined using a 
MTS Nanoindenter XP with a diamond Berkovich indenter. At least 10 indentations 
spaced 100 microns apart were used to estimate the modulus and hardness of the 
specimens adopting the Oliver-Pharr approach [250]. This experimental method was 
created in order to minimize errors due to thermal drift, machine compliance, etc. The 
stiffness was evaluated from the unloading curve by taking the derivative at the inception 
of the best fitted polynomial function with respect to the displacement, i.e. dP/dh. The 
contact area was defined by using a polynomial function obtained by using reference data 
from a fused silica specimen with a known modulus (72.1 GPa from ultrasonic 
measurements) and hardness. The area function was calculated for a depth greater than 
the maximum depth penetrated in the specimens, where the tip radius was calibrated 
using a tungsten specimen.  
The plot of load vs displacement at 500 mN and 200 mN peak loads on different 
surface treated Nitinol alloys are shown in Figure 6.23. Each sample was indented with 
20 indents at different peak loads. Figure 6.23 (a) and (b) show the modulus and hardness 
calculated by using the Oliver Pharr approach (depths above 1000 nm and peak loads 
above 25 mN). The modulus of NiTi alloys (79-98 GPa) increased with the addition of 
alloying elements as did the hardness (3-7.4 GPa) (see Table 6.4 and Figure 6.23).  
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Figure 6.23: Nanoindentation: (a) Peak load vs. displacement and (b) load vs. hardness 
curves for NiTi Alloys. 
Table 6.4: Modulus and hardness calculated from Nano-indentation. 
 
NiTi NiTi5Cr NiTi10Ta 
 
E (GPa) H (GPa) E (GPa) H (GPa) E (GPa) H (GPa) 
Mean 79.4 3.6 97.9 7.4 78.9 3 
Std. Dev. 1.4 0.2 2.0 0.2 4.9 0.2 
6.8 Surface composition of polymer coated Nitinol by FTIR analysis 
 Fourier transform infrared spectroscopy (FTIR) analysis was conducted on 
polymer coated MEP Nitinol alloys. The FTIR peaks for MEP + PC NiTi10Ta and MEP 
+ PC NiTi5Cr are shown in Figure 6.24. 
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Figure 6.24: FTIR spectrum of PGA/PCL polymer coated MEP NiTi5Cr and MEP PC 
NiTi10Ta 
 
The significance of each peak observed in the aforementioned FTIR spectra is 
tabulated in Table 6.5. 
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Table 6.5: Interpretation of FTIR spectra for PGA/PCL polymer coatings 
Experimental 
peak (cm-1) 
Theoretical 
peak (cm-1) 
Possible functional groups 
Characteristic 
material 
3733.5 3720-3770 
Alcoholic OH, vibrational 
stretching without hydrogen 
bonding 
- 
3632 3610-3670 
Vibrational stretching of  OH with 
intermolecular hydrogen bonding 
- 
3050-2750 2980-3040 CH2 vibrations PCL 
2942 2949 Asymmetric C-H stretching PCL 
1747 
1750 very 
strong 
C=O carbonyl stretch (anhydride) PGA, PCL 
1500, 1500 Aromatic C=C - 
1546 1540 C-H bend PGA 
1455 1380-1480 
Vibrational bending of CH group of 
alcoholic group 
- 
1300,1350 1300-1360 
Vibrational bending of double bond 
(C=C) vinyl and bending of CH 
from alcoholic groups 
- 
1300 1294 
C-O and C-C stretching in the 
crystalline phase 
- 
1241 1245 strong Asymmetric COC stretching PCL 
1186 1190 strong OC–O stretching, PCL 
1164 1170 Symmetric COC stretching PCL 
1157 
1160 very 
strong 
C-O and C-C stretching in the 
amorphous phase 
PCL 
1047 1050 short symmetric COC PCL, PGA 
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 The broad peak from 2800-3000 cm-1 belongs to CH2 vibrations displayed by a 
PCL molecule; a strong peak at 1740 cm-1 belongs to C=O stretching vibrations and it is a 
characteristic peak for both PCL and PGA molecules; a strong peak at 1540 cm-1 
corresponds to CH bent vibrations and is a characteristic peak for PGA; 1300-1500 cm-1 
attributed to deformational CH2 vibrations and these peaks are characteristic of aliphatic 
polyesters [251], [252]; a very strong peak at 1157 cm-1 corresponds to C-O and C-C 
stretching vibrations of PCL in amorphous phase; a short peak at 1047 cm-1 corresponds 
to COC vibrations that are characteristic for both PCL and PGA molecules. These FTIR 
peaks denote the presence of amorphous PCL/PGA polymer coatings on the surface of 
MEP treated Nitinol alloys. 
6.8  Wettability and work of adhesion of polymer coated and uncoated NiTi 
Alloys by contact angle meter 
The surface properties of a material are dependent on its surface treatment, which 
can produce different surface texture, surface chemistry, surface energy and wettability 
[59]. It has been reported that the wettability and surface free energy of NiTi significantly 
influence its biological response [253]. 
In order to assess the biological response of NiTi alloys, both their wettability and 
surface energy were determined by measuring their contact angles (CA). A kyova contact 
angle meter was used to determine the contact angle and surface energy of the Nitinol 
alloys. A sessile drop method was used to study the samples using DI water (polar), 
ethylene glycol (neutral) and diiodomethane (non-polar) as the three probe liquids. 
Young-Dupre Equation (6.1) [254] was used to calculate the contact angle: 
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ᵞlv cosθ = ᵞsv - ᵞsl                                 (6.1) 
where ᵞlv - is surface energy of the liquid with respect to vapor, ᵞsl - surface free 
energy related with the interface between solid and probe liquid, ᵞsv - surface energy of 
the solid with respect to vapor and Ө is the contact angle between the probe liquid and 
the examined surface. 
All tests were conducted on each specimen at locations with sufficient spacing, in 
order to prevent any influence of the previous tests. Five samples of each alloy were used 
to measure contact angles. 
A comparative analysis of contact angles for different materials is shown in 
Figure 6.25.  
 
Figure 6.25: A comparison of CA values for different bio-materials (n = 5, mean ± SD).  
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Figure 6.25 indicates that the CA of MP NiTi varied from slightly hydrophobic 
(~95.6 degree) to slightly hydrophilic behavior (MP NiTi5Cr ~ 66.6 and MP NiTi10Ta ~ 
75.9 degree) after alloying of Nitinol with ternary elements such as Ta and Cr. However, 
MEP treatment to MP ternary Nitinol alloys has increased their contact angles and the 
alloys became slightly hydrophobic in nature (MEP NiTi5Cr ~ 91.6 and MEP NiTi10Ta 
~ 85.6). Based on our previous investigation, magneto-electropolished (MEP) surfaces 
were more hydrophobic than the untreated NiTi surfaces. Additionally, the application of 
the biodegradable polymer coating on the MEP Nitinol alloys did not induce any 
significant difference in their CA values. 
CA of biodegradable co-polymer PGA/PCL (90/10) was measured and compared 
with that of the CA values of each individual polymer (from literature) as shown in 
Figure 6.26. The sessile drop contact angle measurements show that the wettability of 
monomeric PCL[255] and PGA/PCL co-polymer are similar, whereas, monomeric PGA 
[256] is slightly hydrophilic in nature.  
 
Figure 6.26: Comparison of contact angles for PGA/ PCL co-polymer with that of 
monomeric polymers *[256], **[255] (n = 5, mean ± SD). 
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Depending on the surface chemistry of a biomaterial, its surface properties 
such  as work  of  adhesion, wettability  and  surface  free  energy will  vary. Among 
these factors, work of adhesion [253] is one such property that effects the adhesion 
of blood components to biomaterials after implantation. 
Mathematically, the work of adhesion (W) [257] of an adhering cell on to a 
solid substrate is expressed as 
W= γSL+ γAL‐ γSA                   (6.2) 
Whereas, the subscripts S, A and L stand for the phases (the solid substrate, 
the adhering cell and  liquid respectively) and  the γ values refer  to  the  interfacial 
tensions between the phases considered.  
In this research, work of adhesion of blood cells on biomaterials (the ease 
with which cells can adhere) can be determined by using Equation (6.2), where the 
biomaterial  is  considered  as  the  solid  substrate,  the blood  as  the  liquid  and  the 
platelets as adhering cells. So the parameters in Equation (6.2) are: γSL corresponds 
to  interfacial  tension between  substrate and  liquid,  γPL corresponds  to  interfacial 
tension between platelet and liquid, γSP corresponds to interfacial tension between 
substrate and platelet. Determination of work of adhesion between platelets and 
biomaterials (used  in blood contacting  implants) acts as a parameter to  interpret 
their long‐term hemocompatibility properties. The surface free energy parameters 
for platelets and liquids used in the experiment are shown in Table 6.6. 
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Table 6.6: Surface free energy parameters (in mN/m)  
Component  γ+  γ‐  γLW 
Platelet membrane[253]  12.26  7.44  99.14 
Distilled water  25.50  25.50  21.80 
Diiodomethane  0  0  50.80 
Ethylene glycol  1.90  47.00  29.00 
 
Table 6.7: Surface free energy parameters (in mN/m)  
Material 
Lewis acid base theory 
γLW γ+ γ‐ 
Avg SD Avg SD Avg SD 
NiTi –MP 23.7 0.75 0.04 0.02 7.75 1.69 
SS – MP 30.78 0.76 0 0 26.2 2.53 
NiTi5Cr-MP 30.02 0.09 0.1 0.05 22.7 0.24 
NTi10Ta-MP 30.4 0.52 0 0 18.73 2.23 
NiTi5Cr-MEP 32.6 0.64 0.2 0.06 3.28 1.28 
NiTi10Ta-MEP 33.3 0.44 0 0 6.12 1.16 
NiTi5Cr - MEP + PC 38.6 0.00 0 0 3.2 0.14 
NiTi10Ta-MEP + PC 40.1 0.14 0 0 3.75 0.21 
PGA/PCL 44.4 0.13 0 0 8.6 0.25 
117 
 
In  Equation  (6.1),  the  interfacial  tension  γij  between  any  two  condensed 
phases  i and  j can be determined using Equation (6.2) as suggested by Good and 
van Oss et al. [258]. 
γij = (√γiLW ‐ √γjLW)2 + 2.(√ γi+ γi‐ + √ γj+ γj‐ ‐ √ γi+ γj‐ ‐ √ γi‐ γj+)                          (6.2) 
The surface free energy parameters presented in Tables 6.6 and 6.7 for each 
individual  component were  incorporated  into Equation  (6.2)  to determine  their 
respective  interfacial  tension  values  as  shown  in  Table  6.8.  Later,  interfacial 
tension values were plugged into Equation (6.1) to determine the work of adhesion 
(W) between platelets and each substrate material as shown in Table 6.8. 
Table 6.8:  Interfacial tension (γij) and work of adhesion (W) parameters for 
different substrate materials with respect to platelets 
Material 
γSL 
(mN/m) 
γPl 
(mN/m) 
γSP 
(mN/m) 
W 
(mN/m) 
NiTi –MP 90.96031  213.9244  215.7929  89.09 
SS – MP 104.3875  213.9244  232.4861  85.83 
NiTi5Cr-MP 102.9839  213.9244  231.391  85.52 
NTi10Ta-MP 103.6867  213.9244  232.6458  84.97 
NiTi5Cr-MEP 107.7172  213.9244  243.082  78.56 
NiTi10Ta-MEP 108.9865  213.9244  243.5328  79.38 
NiTi5Cr - MEP + PC 118.4165  213.9244  258.7004  73.64 
NiTi10Ta-MEP + PC 121.0331  213.9244  262.353  72.60 
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This  data  indicates  that  as  the  interfacial  tension  increases,  the work  of 
adhesion reduces i.e, γij  is inversely proportional to W. 
Therefore, in an effort to understand this effect, the platelet adhesion (PA) 
and work of adhesion (W) values for different substrate materials were plotted in 
Figure  6.27.  It  can  be  inferred  that  less  platelets  adhered  on PC  + MEP Nitinol 
alloys  as  compared  with  that  on  all  other  materials.  Also  the  lowest  work  of 
adhesion was observed for MEP + PC Nitinol alloys. Additionally, MEP treatment 
resulted  in  a  reduction  of  platelet  adhesion  and work  of  adhesion  as  compared 
with that of MP Nitinol alloys.  
 
Figure 6.27: A comparison of work of adhesion and platelet adhesion for various 
alloys 
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A correlation between platelet adhesion and work of adhesion for different 
materials considered under  in this hemocompatibility study was shown  in Figure 
6.28.  
  
Figure 6.28: Correlation between work of adhesion and platelet adhesion. 
 
It can be observed that platelet adhesion increased with an increase in work 
of adhesion, and vice versa. Absolom et al. [259] and Vijayanand et al. [253] have 
mentioned  that  the  adherence  of  blood  components  such  as  platelets  and 
erythrocytes is directly proportional to their work of adhesion with a biomaterial. 
Hence  it can also be  inferred that platelet adhesion  is dependent on the work of 
adhesion of platelets to these alloys.  
Similarly,  using  Equations  6.1  and  6.2  the  theoretical  work  of  adhesion 
values between polymer and MEP  ternary Nitinol alloys were calculated and are 
shown in Table 6.9. 
Table 6.9: Work of adhesion between polymer and MEP Nitinol substrates. 
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Component 
γSL 
(mN/m) 
γPL 
(mN/m) 
γSP 
(mN/m) 
W 
(N/m) 
MEP NiTi5Cr 107.71 128.42 161.08 75.05E-3 
MEP NiTi10Ta 108.98 128.42 169.11 68.29E-3 
 
In this case, γSL corresponds to the interfacial tension between the substrate and 
water, γPL corresponds to the interfacial tension between the polymer and water and γSP 
corresponds to the interfacial tension between the polymer and substrate. The data given 
in Table 6.8 indicates that the work of adhesion of polymer on MEP NiTi5Cr was 
slightly high as compared with that of MEP NiTi10Ta.  
6.3  Mechanical properties of polymer coated Nitinol by nano-scratch tests 
 Drug eluting stents consist of a polymeric carrier coating that elutes anti-
proliferative drugs (sirolimus, novolimus, paclitaxel, etc.) in order to mitigate post-
angioplasty coronary restenosis. Depending on the type of polymer coating ie., either 
biodegradable or durable, the duration of drug elution varies from 3 to 6 months. Polymer 
cracking, delamination, bridging, flaking and non-uniform degradation of polymer 
coating before and after expansion of the stent and during drug elution, might lead to 
emboli formation and inflammatory reactions.  
Generally, scratch tests are used to identify the performance of a material in terms 
of its wear resistance and deformation properties [260]. Scratch induced deformation of a 
coated material can be characterized using either a micro or nano scratch tests depending 
on the material properties [261]. Wolf et al. [262] has demonstrated the usage of atomic 
force micrograph (AFM) to quantify the adhesion forces between the polymer coating 
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and substrate and cohesive forces within the polymeric layers of a drug-eluting stent 
(DES). A model coupon that represents each pair of layers in CYPHER1 Sirolimus-
eluting coronary stent was used to study the aforementioned properties. This DES 
consists of a stainless steel stent substrate, a parylene C primer layer, and a drug-eluting 
layer that contains poly (ethylene-co-vinyl acetate), poly (n-butyl methacrylate), and 
sirolimus (rapamycin).  
 Shan et al. [263] developed a push-out testing technique that utilized a probe to 
determine the critical force for failure of the film substrate interface (adhesion) and 
critical force for penetration of the film (cohesion). A model drug-eluting stent (the 
Nevo™ Sirolimus Eluting Coronary Stent) containing suspended microscopic polymeric 
films in metallic Co-Cr alloy reservoirs  was used for the measurement of adhesion and 
cohesion forces. 
 In this study a nano-scratch test method was applied to characterize the adhesion 
properties of the polymer coating on MEP treated Nitinol substrates. The nano scratch 
tests were performed by using a CSM nano-scratch tester at Uppsala University (Uppsala, 
Sweden) with a cube-corner diamond tip (C-B37).  
6.8.1 Principle of scratch test 
 In the scratch test method, an indentor of defined geometry is drawn across the 
surface of a coated test specimen at a constant speed and a defined normal force, FN 
(progressively increasing) for a defined distance. The damage along the scratch track is 
microscopically assessed as a function of the applied force. Specific levels of 
progressive damage are associated with increasing normal stylus forces. According to 
ASTM D7187, critical failure load (Lc1) is defined as the onset of fracture at the point 
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where the normal force (FN), tangential force (FT) and penetration depth (PD) begin to 
fluctuate wildly. A sudden drop in PD and an increase in FN corresponds to complete 
delamination of polymer coating from the substrate. The driving forces for coating 
damage in the scratch test are a combination of elastic-plastic indentation stresses, 
frictional stresses and the residual internal stresses. The test method also describes the 
use of tangential force and acoustic emission signals as secondary test data to identify 
different coating failure types. The viscoelastic characteristics of the polymer greatly 
influence how the material deforms under the indenter tip, and how it recovers after the 
deformation has occurred. 
6.8.2 Methodology of scratch test: 
During nano-scratch testing, each sample was first cleaned with compressed air to 
remove any comtaminants and then it was mounted on the stage to perform the analysis. 
The working parameters used during nano-scratch testing are provided in Table 6.10. 
Table 6.10: The operating parameters for nano scratch tests 
Working parameters Nano-indentation test 
Initial load (mN) 0.3 
Final load (mN) 120 
Speed (µm/min) 700 
Length (µm) 2500 
Indentation tip Cube corner diamond tip (C-B 37) 
 
A typical progressive load- depth of penetration curve obtained during scratch 
tests for MEP + PC NiTi5Cr is shown in Figure 6.29.   
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Figure 6.29: A typical scratch test curve for MEP + PC NiTi5Cr. The measurement 
signals are identified and color coded as FN: Applied normal load (Brown), PD: 
Penetration depth during scratch (Turquoise) RD: Residual Depth after scratch (Green), 
AE: Acoustic Emission (Dark Blue), μ: Friction coefficient (Red), and Ff: Friction force 
(Purple). 
As mentioned earlier, at critical failure load (Lc) or Fcritical for MEP + PC 
NiTi5Cr, a sudden drop in PD and an increase in FN were observed and this point 
corresponds to the complete delamination of polymer coating from the substrate. The 
failure load (Lc) obtained from nano-scratch test is directly proportional to interfacial 
adhesion strength between the polymer and the substrate. The critical delamination loads 
for both polymer coated MEP ternary Nitinol alloys are shown Table 6.11.  
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Table 6.11: Adhesion energies of polymer coated Nitinol obtained from nano-scratch 
tests 
Variable Fi (mN) 
Fi+1 
(mN) 
Fcritical 
(mN) 
Xi 
(mm) 
Xi+1 
(mm) E (J) 
MEP + PC 
NiTi10Ta 0.2121 84.84 7.847 0 0.23 8.669E-05 
MEP + PC 
NiTi5Cr 0.2121 84.84 7.635 0 0.22 8.722E-05 
 
 
              (1) 
 
 Equation (1) was used to determine the polymer adhesion energy values (E) 
utilizing lateral critical failure loads (Fcritical) obtained from nano-scratch analysis [264], 
where, xi corresponds to the starting point at which the load was applied and xi+1 
corresponds to the point where maximum load was applied. Similarly, Fi corresponds to 
the initial lateral load, Fi+1 correspond to the final lateral load and Fcritical corresponds to 
the critical lateral delamination load where polymer coating delamination occurs. The 
adhesion energy values are also provided in Table 6.11. 
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CHAPTER 7 
DISCUSSIONS 
7.1 Biocompatibility of Nitinol alloys  
In this investigation, emphasis was placed on determining the bio and hemo-
compatibility properties of biodegradable polymer coated and surface treated ternary 
Nitinol alloys. Both these properties of polymer coated Nitinol alloys were controlled by 
their inherent characteristics such as, corrosion resistance, surface topography, surface 
chemistry and wettability. Surface treatment and application of polymer coatings on 
Nitinol alloys in turn affected the aforementioned properties. Reduced corrosion rate, 
lower amount of leached metallic ions, reduced platelet adhesion and improved 
endothelial cell growth were observed for MEP treated and polymer coated Nitinol alloys 
as compared with their respective MP alloys. Under the specified hemocompatibility tests 
conditions, a correlation between the number of platelets adhered on a substrate and its 
corresponding work of adhesion with the platelets was observed. 
7.2 Surface characterization of Nitinol alloys  
MEP Ternary Nitinol alloys displayed a micro textured surface. The preferential 
dissolution resulted in morphological changes that were dependent on the alloying 
element, whereby, grain boundaries in the case of MEP NiTi10Ta produced crests, 
whereas those on MEP NiTi5Cr produced valleys. SEM/EDS analysis of MEP NiTi10Ta 
indicated that, the dispersion of the ternary element Ta was non-homogenous throughout 
the alloy with precipitates of high Ta composition (> 20 at %) at the grain boundaries as 
compared with that within the grain (~ 8 at %). Similarly, the concentration of Cr in MEP 
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NiTi5Cr was high (> 15 at %) at the grain boundaries as compared with that in the grain 
(~ 5 at %). Whereas, prior to MEP, EDS analysis of MP NiTi5Cr revealed that the 
concentration of Cr on the surface was homogenous. This was attributed to preferential 
dissolution of Ni at grain boundaries leaving behind the chromium oxide during MEP. 
Increased amounts of Cr and O at the grain boundaries after MEP of NiTi5Cr might lead 
to the formation of a passive Cr2O3  layer at the grain boundaries and could have resulted 
in reduced corrosion and metallic ion leaching.  
The surface roughness of MP NiTi5Cr alloys was slightly reduced after MEP 
treatment, and even polymer coating made little difference; whereas that of NiTi10Ta 
alloy remained unchanged even after the surface treatment.  
XPS analysis revealed that higher amounts on metallic Ni and NiO and lower 
amounts of Ni(OH)2 were found on the surface of MEP NiTi10Ta as compared with that 
of MEP NiTi5Cr (Table 6.3). This presence of metallic Ni on the surface of a Nitinol can 
cause leaching of Ni during its corrosion. ICPMS analysis of corrosion liquids obtained 
from potentiodynamic in-vitro corrosion tests revealed higher amounts of leached Ni ions 
indicated MEP NiTi10Ta as compared with that of MEP NiTi5Cr (Table 5.1). These 
results show that surface composition of Nitinol is one factor that controls the leaching of 
Ni ions from its surface. Haider et al. [233] showed that MEP treatment on Nitinol 
resulted in lower Ni release during in-vitro corrosion studies. 
7.3 Corrosion analysis of polymer coated Nitinol alloys 
Potentiodynamic corrosion studies revealed that, application of MEP treatment to 
NiTi10Ta and NiTi5Cr ternary Nitinol alloys resulted in reduced corrosion rates. This 
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reduction in corrosion rate can be attributed to the formation of an improved oxide layer 
on the surface of these ternary Nitinol alloys during MEP treatment. Additionally, the 
application of polymer coating on MEP treated Nitinol alloys further reduced their 
corrosion rate by one order of magnitude as compared with their MP counterparts. This 
can be attributed to the presence of polymer coating on the metal’s surface which acts as 
a protective barrier against corrosion. Similarly, Mazumder et al. [265] showed that 
application of polyurethane-coating on Nitinol cardiovascular stents has reduced their in-
vitro corrosion rate from 275 µm/year to less than 13 µm/year.   
Cyclic potentiodynamic polarization curves of MP, MEP and MEP+PC NiTi10Ta 
showed a similar anodic dissolution behavior with a positive hysteresis loop. This 
revealed that they all undergo pitting corrosion after the break down of passive layer (Eb) 
in the forward scan and undergo pitting corrosion until the repassivation of oxide layer 
occurs (Ep)  in the reverse scan. Whereas, MP, MEP and MEP + PC NiTi5Cr alloys 
displayed cyclic polarization curves with negative hysteresis loop. This revealed that 
during the reverse scan, no localized corrosion occurred at the surface of NiTi5Cr alloy. 
In general, the MEP surface treatment and application of polymer coating on MP ternary 
Nitinol alloys have reduced the corrosion rate of by one order of magnitude as shown in 
Table 3.1. The corrosion rates for NiTi5Cr alloy were in the following order: MP 
NiTi5Cr > MEP NiTi5Cr > MEP + PC NiTi5Cr and the corrosion rate for NiTi10Ta alloy 
were: MP NiTi10Ta > MEP NiTi10Ta > MEP + PC NiTi10Ta. 
EIS analysis of polymer coated ternary Nitinol alloys revealed that the polymer 
coating acts as a protective barrier during corrosion, with a high coating pore resistance 
(Rpore). As the Rpore and charge transfer resistance (RP) of MEP + PC NiTi5Cr were higher 
128 
 
than that of MEP + PC NiTi10Ta, it indicated that the polymer coating on the former 
alloy was superior. 
7.4 Adhesion and interfacial bond between polymer and substrate 
Adhesion is defined [266] as "the state in which two surfaces are held together by 
interfacial forces which may consist of valence forces or interlocking forces or both." The 
nature of bond formed at the interface between a coating and its substrate affects its 
adhesion properties. Figure 7.1 [267] shows the bonding energy related to different 
interfacial bonds formed across the coating/substrate interface. The effective contact area 
between coating and its substrate is directly proportional to its adhesion properties.  
 
Figure 7.1: Relative bond strengths for a range of potential interfacial bonding [267] 
 
  Antico, et al. [268] utilized chemical functionalization to improve 
adhesion between NiTi surfaces and a thermoplastic polyolefin (TPO) matrix. Smith, et 
al. [269] observed that covalent bonding of silane group to NiTi substrates prior to poly 
(methylmethacrylate, plexiglas) polymer coating substantially improved the interfacial 
interactions between them. In this research, MEP Nitinol alloys were coated with a 
biodegradable polymer composed of PCL/PGA as a precursor to investigate the efficacy 
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of drug elution, which is instrumental in reducing the risk of in-stent and late-stent 
thrombosis. The MEP treatment on these alloys will result in better adhesion and 
mechanical interlocking between the polymer and substrate. 
XPS analysis revealed the presence of Ni (OH)2 on the surface of MEP treated 
ternary Nitinol alloys. As mentioned earlier, the presence of – (OH) bonds on the surface 
of these alloys can lead to the formation of hydrogen bonding between the polymer and 
the substrate. The two steps involved in polymer coating the metallic samples and the 
hydrogen bond formed between the polymer/substrate are shown in Figure 7.2.  
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Figure 7.2: Formation of hydrogen bond at the interface of polymer/substrate due to dip 
coating 
It can be emphasized that MEP treatment of Nitinol alloys can result in 
mechanical interlocking and hydrogen bond formation between the polymer coating and 
the metal surface.  
Biodegradable polymer coated MEP ternary Nitinol alloys were subjected to 
nano-scratch test to identify the adhesion strength of the polymer coating. These tests 
revealed that the critical delamination force (Lc) required to completely delaminating the 
polymer coating from these alloys was similar for both the alloys (MEP + PC NiTi5Cr – 
10.8 mN and MEP + PC NiTi10Ta – 11.1 mN. Critical delamination load obtained from 
scratch test of a coated substrate is a direct indicator of the adhesion strength between the 
coating and the substrate. 
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7.4 Endothelial cell viability and cytotoxicity of polymer coated Nitinol alloys  
Proper endothelialization of cardiovascular implants after implantation plays a 
key role in avoiding in-stent restenosis [270] and growth of neointimal proliferation 
[271]. Additionally, endothelialization is  to reduce thrombosis by around 52% [272]. In 
this investigation, approximately 50×103 HUVEC cells were seeded on to polymer coated 
and uncoated samples (placed into a 24-well plate) and incubated for 48 hours to assess 
the proliferation. After fixing the samples, the cell growth was observed using an SEM. 
The presence of a monolayer of HUVEC cells, with extended fillopodia after 48 hours of 
incubation, indicated that both the MEP surface and co-polymeric coating were 
conducive for cell growth. The number of cells observed on the MEP NiTi10Ta appeared 
to be greater than that on the MEP NiTi5Cr (Figures 5.9 and 5.10). This was attributed to 
its surface topography, wettability and composition. However, further studies should be 
conducted on actual stent designed from the aforementioned material to confirm this 
preferential growth. 
The cytotoxicity of ions leached during corrosion of polymer coated and uncoated 
ternary Nitinol alloys was studied on HUVEC cells for a duration of 2, 4 and 7 days. 
These studies revealed that, significantly lower cytotoxicity on HUVEC cells was 
observed for corrosion liquids obtained from MEP NiTi5Cr and MEP + PC NiTi5Cr as 
compared with that of MP NiTi5Cr (Figures 5.3 to 5.5). This was directly related to the 
reduced concentration of Ni and Cr released from the uncoated and coated MEP NiTi5Cr 
by ICPMS analysis (Figures 5.1 and 5.2). Since a biodegradable polymer was used as a 
coating on Nitinol alloys, it is expected to degrade completely after a certain period, 
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which exposes the metallic surface to the complex arterial environment. Even with the 
absence of polymer coating, MEP treated ternary Nitinol displayed better hemo and 
biocompatibility properties as compared to just MP alloys. So it can be predicted that 
MEP treatment and polymer coating will result in better longevity of Nitinol alloys for 
cardiovascular stent applications. 
7.5 Hemocompatibility of polymer coated Nitinol alloys 
In general, implants with surfaces in contact with blood can initiate activation, 
secretion, adherence, and aggregation of platelets and trigger subsequent plasmatic 
coagulation and immunological responses, depending on the material’s 
hemocompatibility [207]. Spreading of platelets and the secretion of their stored 
constituents lead to further platelet aggregation [208]. Hemocompatibility of a 
cardiovascular implant material plays a major role in its thrombogenicity. Surface 
properties of a material mainly control its hemocompatibility which can be understood by 
investigating the affinity of various blood components (platelets, fibrinogen, etc.) towards 
its surface. In this study, the polymer coated and uncoated Nitinol alloys were subjected 
to platelet adhesion studies to determine their hemocompatibility. These studies revealed 
that the polymer coated MEP ternary Nitinol alloys were more hemocompatible than the 
mechanically polished ternary Nitinol alloys and were less thrombogenic as compared 
with the standard material, stainless steel commonly used for manufacturing stent (Figure 
5.14). 
Even though the initial findings indicate that polymer coated MEP ternary Nitinol 
alloys for blood contacting applications appears to be promising, further conclusive 
133 
 
testing is still needed. A primary limitation of this study was that the concentration of 
activated blood proteins such as prothrombin and fibrinogen, critical precursors to 
thrombus formation, were not assessed. Moreover, even though platelet adhesion on the 
materials surfaces was determined, the total number of activated platelets in the 
circulating blood was not examined.  
7.6 Correlation between work of adhesion and cellular adhesion 
 The net change in surface free energy is the main driving factor that decides the 
extent of cellular adhesion and interaction on to a given solid substrate [253]. A reduction 
in surface free energy (possible minimum equilibrium value) will favor cell adhesion 
process. Work of adhesion of cells (which is the negative of surface free energy change) 
on to a substrate reflects the ease with which cells adhere to a given solid substrate from a 
given liquid environment [253]. Additionally, attractive van der Waal’s forces and 
plurivalent cation bridging control the cell adhesion process on various substrates such as 
glass, polymers, metals, lipids and collagens [273].  
 Mathematically, the work of adhesion [274] of an adhering cell on to a blood 
contacting biomaterial in blood is expressed as: 
WA = γSL + γCL - γSC 
where the subscripts L - liquid or blood, S – substrate or implant and C – adhering cell 
and γ represents interfacial tensions between the given two phases. 
 The interfacial tension between any two condensed phases j and i in terms of their 
surface energy parameters is expressed by below Equation (7.1) [275]. 
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γij = (√γiLW - √γjLW)2 + 2.( √γi+ γi- + √γj+ γj- - √γi+ γj- - √γi- γj+ )   (7.1) 
The platelet adhesion values and work of adhesion values for different materials 
under hemocompatibility study are plotted in Figure7.3. This shows that as the work of 
adhesion between the platelets and the substrate material reduced, the amount platelets 
adhered to their surface also reduced. The MEP + PC Nitinol alloys displayed the lowest 
amount of platelets adhered as well as lowest work of adhesion values as compared to the 
rest of the MP alloys. 
 
Figure 7.3: Variation of platelet adhesion w. r. to work of adhesion for different materials 
The correlation between platelet adhesion (PA) and work of adhesion (W) of 
platelet to substrate were plotted against each other, where they followed a relationship as 
shown in Figure 7.4. Similarly, absolom et al. [276] showed that the adhesion of 
erythrocytes reduced as the work of adhesion of the biomaterial reduced. These results 
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indicate that based on the work of adhesion of the biomaterial its hemocompatibility can 
be predicted.  
 
Figure 7.4: A correlation between work of adhesion and platelet adhesion 
The number density of platelet adhesion (PA) on biomaterials directly correlates 
with their work of adhesion between the substrate and platelets (W), according to y = -
0.0212x2 + 5.5332x - 265.87, where x is W (mN/m) and y is PA (platelets/mm2). This 
equation can be used to predict the platelet that can get adhered (thrombogenic nature) to 
the surface of a biomaterial by using its work of adhesion values. 
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CHAPTER 8 
CONCLUSIONS 
The work conducted in this dissertation was mainly on investigating the bio and 
hemocompatibility properties of biosorbable polymer coated and surface treated ternary 
Nitinol alloys for drug eluting stent applications. The ternary Nitinol alloys were first 
subjected to magneto-electropolishing (MEP) treatment and then coated with a novel 
biodegradable co-polymer, polycaprolactone (PCL)/poly glycolic acid (PGA) in the ratio 
of 90/10. The electrochemical, surface morphological and mechanical properties were 
assessed for both the individual materials as well as the polymer coated alloys.  
The results obtained in this investigation have indicated that biosorbable polymer 
coated MEP ternary Nitinol alloys have great potential as an implant material for 
cardiovascular stent and other implant applications. The following are conclusions 
derived from this research:  
 Electrochemical properties were assessed by EIS and potentiostat. MEP treatment 
and application of polymer coating have resulted in reduction of corrosion rate in 
the following order: 
o MP NiTi5Cr (3.80E-01 mpy) > MEP NiTi5Cr (9.43E-02 mpy) > MEP + 
PC NiTi5Cr (1.27E-02 mpy) 
o MP NiTi10Ta (1.35E-01 mpy) > MEP NiTi10Ta (8.81E-02 mpy) > MEP 
+ PC NiTi10Ta (4.79E-02 mpy) 
 EIS analysis of uncoated and coated MEP ternary Nitinol alloys indicated that 
MEP + PC NiTiCr has higher pore resistance (Rpore) and charge transfer resistance 
(Rp ) as compared with that of MEP + PC NiTi10Ta alloy, which indicates that the 
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polymer coating on the former alloy has a better corrosion resistance than the 
latter alloy. 
 Polymer coating acts as a protective layer that inhibits the contact of electrolyte 
from reaching the metal surface on MEP NiTi5Cr. It also prevents the migration 
of Ni ions into the environment which corresponds to reduced toxicity on human 
primary umbilical vein endothelial cells (HUVEC). 
 Polymer coated MEP Nitinol alloys displayed lower platelet adhesion as 
compared with that on MEP and MP Nitinol alloys, 316 SS and binary Nitinol 
alloys. Lowest work of adhesion (W) between the platelets and the substrate 
surfaces was observed for MEP + PC Nitinol alloys. As the W value for a 
material decreased, the no. of platelets adhered on its surface decreased, showing 
that W is directly proportional to the platelet adhesion.  
 XPS analysis revealed that MEP treatment on NiTi5Cr has reduced the amounts 
of Ni and NiO which corroborates with the low Ni in the electrolyte after 
corrosion is consistent with the low Ni release from MEP NiTi5Cr.  
 Ni(OH)2 on the surface of MEP alloys might have contributed to formation of 
hydrogen bonding (-OH bond) between the polymer and the metal surface. 
 Nano-scratch analysis revealed the lateral critical failure loads (Lc) for MEP 
NiTi5Cr and MEP NiTi10Ta in the range of 7.8 mN to 7.6 mN respectively. The 
adhesion between the polymer and the alloys can be attributed to the formation of 
hydrogen bonds.  
 The viability and confluency of HUVEC cell growth on MEP and MEP +PC 
Nitinol alloys were high as compared with MP Nitinol alloys. 
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 Coating ternary NiTi5Cr and NiTi10Ta with a PCL/PGA polymer enhanced their 
anti-thrombogenic nature. 
 The number density of platelet adhesion (PA) on biomaterials directly correlates 
with their work of adhesion between the substrate and platelets (W),  according to 
the equation y = -0.0212x2 + 5.5332x - 265.87, where x is W (mN/m) and y is PA 
(platelets/mm2) 
The findings of this research will be useful for introducing novel biosorbable 
polymeric coated MEP Nitinol alloys for enhanced drug eluting stents (DES) 
applications. Based on the results from the current work, the DES manufactured from 
these alloys is expected to provide improved biocompatibility with reduced 
thrombogenicity as compared with currently used implant materials.   
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CHAPTER 9 
RECOMMENDATIONS FOR FUTURE RESEARCH 
 
The aim of the current research was to explore the potential of the polymer coated 
and MEP treated ternary Nitinol alloys for drug-eluting stent and other cardiovascular 
implant applications. Preliminary studies were conducted in this dissertation and further 
research in terms of fibrinogen and other protein adhesion, need to be conducted to 
further elucidate the thrombogenicity and in-vivo response of these alloys. 
The results obtained are very promising, however, further investigation of hemo 
and biocompatibility properties of polymer coatings with an anti-proliferative drug 
embedded into it will determine the usefulness of proposed compositions and surface 
treatments. 
Some of the other recommendations for future work: 
 Analyze the effect of polymer composition on its bio and hemocompatibility 
properties 
 Conduct fatigue failure analysis of the PC + MEP treated ternary Nitinol 
stents/wires 
 Determine in-vitro and in-vivo drug elution profiles of polymer coated stents 
 Design and manufacture stents for in-vivo implantation in rabbits 
 Thrombogenicity studies of polymer coating: fibrinogen and other protein 
adhesion on polymer coated alloys 
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